US20180085477A1 - Method for manufacturing bubbles - Google Patents
Method for manufacturing bubbles Download PDFInfo
- Publication number
- US20180085477A1 US20180085477A1 US15/565,111 US201615565111A US2018085477A1 US 20180085477 A1 US20180085477 A1 US 20180085477A1 US 201615565111 A US201615565111 A US 201615565111A US 2018085477 A1 US2018085477 A1 US 2018085477A1
- Authority
- US
- United States
- Prior art keywords
- bubbles
- container
- manufacturing
- aqueous liquid
- manufacturing container
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 252
- 238000000034 method Methods 0.000 title claims abstract description 85
- 239000007788 liquid Substances 0.000 claims abstract description 175
- 239000000654 additive Substances 0.000 claims abstract description 45
- 230000000996 additive effect Effects 0.000 claims abstract description 41
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 8
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 7
- 150000003839 salts Chemical class 0.000 claims abstract description 7
- 235000000346 sugar Nutrition 0.000 claims abstract description 6
- 150000008163 sugars Chemical class 0.000 claims abstract description 6
- 239000007789 gas Substances 0.000 description 49
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 33
- 239000012153 distilled water Substances 0.000 description 20
- 238000003745 diagnosis Methods 0.000 description 19
- 230000035939 shock Effects 0.000 description 15
- 210000004204 blood vessel Anatomy 0.000 description 13
- 229910001868 water Inorganic materials 0.000 description 12
- 239000000243 solution Substances 0.000 description 10
- 239000007924 injection Substances 0.000 description 9
- 238000002347 injection Methods 0.000 description 9
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 7
- 239000008103 glucose Substances 0.000 description 7
- 239000011800 void material Substances 0.000 description 7
- 206010028980 Neoplasm Diseases 0.000 description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
- 201000011510 cancer Diseases 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 235000013305 food Nutrition 0.000 description 6
- 239000002101 nanobubble Substances 0.000 description 6
- QYSGYZVSCZSLHT-UHFFFAOYSA-N octafluoropropane Chemical compound FC(F)(F)C(F)(F)C(F)(F)F QYSGYZVSCZSLHT-UHFFFAOYSA-N 0.000 description 6
- 229960004065 perflutren Drugs 0.000 description 6
- 238000002360 preparation method Methods 0.000 description 6
- 238000007789 sealing Methods 0.000 description 6
- 238000009826 distribution Methods 0.000 description 4
- -1 ethylene, propylene, propadiene Chemical class 0.000 description 4
- 238000011282 treatment Methods 0.000 description 4
- 102000009027 Albumins Human genes 0.000 description 3
- 108010088751 Albumins Proteins 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 210000004556 brain Anatomy 0.000 description 3
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 3
- 239000002961 echo contrast media Substances 0.000 description 3
- 239000003978 infusion fluid Substances 0.000 description 3
- 150000002500 ions Chemical class 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- OFBQJSOFQDEBGM-UHFFFAOYSA-N n-pentane Natural products CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 3
- 239000002105 nanoparticle Substances 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 239000002953 phosphate buffered saline Substances 0.000 description 3
- 239000002504 physiological saline solution Substances 0.000 description 3
- 238000010926 purge Methods 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- SFZCNBIFKDRMGX-UHFFFAOYSA-N sulfur hexafluoride Chemical compound FS(F)(F)(F)(F)F SFZCNBIFKDRMGX-UHFFFAOYSA-N 0.000 description 3
- 229960000909 sulfur hexafluoride Drugs 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- 238000002604 ultrasonography Methods 0.000 description 3
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- RGSFGYAAUTVSQA-UHFFFAOYSA-N Cyclopentane Chemical compound C1CCCC1 RGSFGYAAUTVSQA-UHFFFAOYSA-N 0.000 description 2
- 229920001353 Dextrin Polymers 0.000 description 2
- 239000004375 Dextrin Substances 0.000 description 2
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 2
- 102000006395 Globulins Human genes 0.000 description 2
- 108010044091 Globulins Proteins 0.000 description 2
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 2
- 229910018503 SF6 Inorganic materials 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 235000019425 dextrin Nutrition 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 230000001678 irradiating effect Effects 0.000 description 2
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 2
- 229960004692 perflenapent Drugs 0.000 description 2
- KAVGMUDTWQVPDF-UHFFFAOYSA-N perflubutane Chemical compound FC(F)(F)C(F)(F)C(F)(F)C(F)(F)F KAVGMUDTWQVPDF-UHFFFAOYSA-N 0.000 description 2
- 229950003332 perflubutane Drugs 0.000 description 2
- NJCBUSHGCBERSK-UHFFFAOYSA-N perfluoropentane Chemical compound FC(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F NJCBUSHGCBERSK-UHFFFAOYSA-N 0.000 description 2
- 230000005514 two-phase flow Effects 0.000 description 2
- VXNZUUAINFGPBY-UHFFFAOYSA-N 1-Butene Chemical compound CCC=C VXNZUUAINFGPBY-UHFFFAOYSA-N 0.000 description 1
- PMPVIKIVABFJJI-UHFFFAOYSA-N Cyclobutane Chemical compound C1CCC1 PMPVIKIVABFJJI-UHFFFAOYSA-N 0.000 description 1
- LVZWSLJZHVFIQJ-UHFFFAOYSA-N Cyclopropane Chemical compound C1CC1 LVZWSLJZHVFIQJ-UHFFFAOYSA-N 0.000 description 1
- 238000012276 Endovascular treatment Methods 0.000 description 1
- OTMSDBZUPAUEDD-UHFFFAOYSA-N Ethane Chemical compound CC OTMSDBZUPAUEDD-UHFFFAOYSA-N 0.000 description 1
- 239000007836 KH2PO4 Substances 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 239000003570 air Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Natural products C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 description 1
- 230000003466 anti-cipated effect Effects 0.000 description 1
- 229910052786 argon Inorganic materials 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 239000001273 butane Substances 0.000 description 1
- IAQRGUVFOMOMEM-UHFFFAOYSA-N butene Natural products CC=CC IAQRGUVFOMOMEM-UHFFFAOYSA-N 0.000 description 1
- UBAZGMLMVVQSCD-UHFFFAOYSA-N carbon dioxide;molecular oxygen Chemical compound O=O.O=C=O UBAZGMLMVVQSCD-UHFFFAOYSA-N 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- 229910000397 disodium phosphate Inorganic materials 0.000 description 1
- BPFZRKQDXVZTFD-UHFFFAOYSA-N disulfur decafluoride Chemical compound FS(F)(F)(F)(F)S(F)(F)(F)(F)F BPFZRKQDXVZTFD-UHFFFAOYSA-N 0.000 description 1
- 239000008151 electrolyte solution Substances 0.000 description 1
- 229940021013 electrolyte solution Drugs 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 125000002534 ethynyl group Chemical group [H]C#C* 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000009313 farming Methods 0.000 description 1
- 238000004388 gamma ray sterilization Methods 0.000 description 1
- 230000002070 germicidal effect Effects 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 150000004820 halides Chemical class 0.000 description 1
- 239000001307 helium Substances 0.000 description 1
- 229910052734 helium Inorganic materials 0.000 description 1
- SWQJXJOGLNCZEY-UHFFFAOYSA-N helium atom Chemical compound [He] SWQJXJOGLNCZEY-UHFFFAOYSA-N 0.000 description 1
- DMEGYFMYUHOHGS-UHFFFAOYSA-N heptamethylene Natural products C1CCCCCC1 DMEGYFMYUHOHGS-UHFFFAOYSA-N 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 150000002431 hydrogen Chemical class 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 239000011261 inert gas Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 229910052743 krypton Inorganic materials 0.000 description 1
- DNNSSWSSYDEUBZ-UHFFFAOYSA-N krypton atom Chemical compound [Kr] DNNSSWSSYDEUBZ-UHFFFAOYSA-N 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- IJDNQMDRQITEOD-UHFFFAOYSA-N n-butane Chemical compound CCCC IJDNQMDRQITEOD-UHFFFAOYSA-N 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- QIYZKVMAFMDRTP-UHFFFAOYSA-N pentafluoro(trifluoromethyl)-$l^{6}-sulfane Chemical compound FC(F)(F)S(F)(F)(F)(F)F QIYZKVMAFMDRTP-UHFFFAOYSA-N 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 239000001294 propane Substances 0.000 description 1
- MWWATHDPGQKSAR-UHFFFAOYSA-N propyne Chemical compound CC#C MWWATHDPGQKSAR-UHFFFAOYSA-N 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 238000000790 scattering method Methods 0.000 description 1
- 235000014102 seafood Nutrition 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 239000001540 sodium lactate Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 229910021642 ultra pure water Inorganic materials 0.000 description 1
- 239000012498 ultrapure water Substances 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 238000004065 wastewater treatment Methods 0.000 description 1
- 229910052724 xenon Inorganic materials 0.000 description 1
- FHNFHKCVQCLJFQ-UHFFFAOYSA-N xenon atom Chemical compound [Xe] FHNFHKCVQCLJFQ-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5089—Processes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B8/00—Diagnosis using ultrasonic, sonic or infrasonic waves
- A61B8/06—Measuring blood flow
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
- A61K49/0045—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent agent being a peptide or protein used for imaging or diagnosis in vivo
- A61K49/0047—Green fluorescent protein [GFP]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/22—Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations
- A61K49/222—Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations characterised by a special physical form, e.g. emulsions, liposomes
- A61K49/223—Microbubbles, hollow microspheres, free gas bubbles, gas microspheres
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5052—Proteins, e.g. albumin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N7/00—Ultrasound therapy
-
- B01F11/00—
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
- B01F23/00—Mixing according to the phases to be mixed, e.g. dispersing or emulsifying
- B01F23/20—Mixing gases with liquids
-
- B01F3/04—
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
- B01F31/00—Mixers with shaking, oscillating, or vibrating mechanisms
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65B—MACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING
- B65B3/00—Packaging plastic material, semiliquids, liquids or mixed solids and liquids, in individual containers or receptacles, e.g. bags, sacks, boxes, cartons, cans, or jars
- B65B3/003—Filling medical containers such as ampoules, vials, syringes or the like
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
- B65D51/00—Closures not otherwise provided for
- B65D51/002—Closures to be pierced by an extracting-device for the contents and fixed on the container by separate retaining means
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B8/00—Diagnosis using ultrasonic, sonic or infrasonic waves
- A61B8/48—Diagnostic techniques
- A61B8/481—Diagnostic techniques involving the use of contrast agent, e.g. microbubbles introduced into the bloodstream
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/28—Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N7/00—Ultrasound therapy
- A61N2007/0039—Ultrasound therapy using microbubbles
Definitions
- the present invention relates to a method for manufacturing bubbles.
- the bubbles are constituted with an outer shell, which is constituted with a protein, a lipid, or the like, and a gas sealed in the outer shell.
- an ultrasonic diagnosis is known which is for making a diagnosis for target site of diagnosis such as chest or abdomen by using such bubbles as an ultrasound contrast agent.
- a diagnosis is made by injecting the bubbles into a blood vessel, irradiating the target site of the diagnosis where the bubbles gather with ultrasonic waves, and making reflected waves (reflection echo) from the target site of the diagnosis into an image.
- bubbles in which a gene or a medical agent (drug) is sealed are injected into a blood vessel and transported to an affected site through the blood flow.
- ultrasonic waves are radiated to the bubbles such that the bubbles burst.
- the drug sealed in the bubbles can be selectively supplied to the affected site.
- the supersaturation bubble generation method is a method in which a gas is dissolved under a high pressure in a mixed liquid containing constituent materials of the bubbles and physiological saline, and then the pressure is reduced such that the bubbles are generated in the mixed liquid.
- the gas-liquid two-phase flow swirling method is a method in which the aforementioned mixed liquid is stirred at a high speed such that the mixed liquid swirls, a gas is allowed to sufficiently drawn into the swirl, and then the occurrence of swirl is stopped such that the bubbles are generated in the mixed liquid.
- An object of the present invention is to provide a method for manufacturing bubbles that makes it possible to easily and reliably adjust a diameter (size) of generated bubbles.
- a method for manufacturing bubbles including
- a diameter of the generated bubbles can be reliably adjusted.
- FIG. 1 is a flow chart for illustrating a method for manufacturing bubbles of the present invention.
- FIG. 2 shows views (cross-sectional views of a bubble manufacturing container) for illustrating the method for manufacturing bubbles of the present invention.
- FIG. 3 is a view for illustrating a state where an aqueous liquid violently collides with an inner surface (top surface) of a container in a step shown in FIG. 2( c ) .
- FIG. 4 is a flow chart for illustrating a second embodiment of the method for manufacturing bubbles of the present invention.
- FIG. 5 shows views (cross-sectional views of a bubble manufacturing container) for illustrating the second embodiment of the method for manufacturing bubbles of the present invention.
- FIG. 6 is a flow chart for illustrating a third embodiment of the method for manufacturing bubbles of the present invention.
- FIG. 7 is a graph showing diameter distributions of bubbles obtained in Examples 1 to 8.
- FIG. 8 is a graph showing diameter distributions of bubbles obtained in Examples 8 to 12.
- FIG. 1 is a flow chart for illustrating the first embodiment of the method for manufacturing bubbles of the present invention.
- FIGS. 2( a ) to 2( d ) are views (cross-sectional views of a bubble manufacturing container) for illustrating the first embodiment of the method for manufacturing bubbles of the present invention.
- FIG. 3 is a view for illustrating a state where an aqueous liquid violently collides with an inner surface (top surface) of a container in a step shown in FIG. 2( c ) .
- top the upper side in each of FIGS. 2( a ) to 2( d ) and in FIG. 3 will be referred to as “top”, and the lower side in each of FIGS. 2( a ) to 2( d ) and in FIG. 3 will be referred to as “bottom”.
- Step [S 1 ] is a step of preparing a bubble manufacturing container (hereinafter, simply referred to as “manufacturing container”) into which the aqueous liquid is injected.
- Step [S 2 ] is a step of injecting the aqueous liquid into the manufacturing container to a predetermined height.
- Step [S 3 ] is a step of sealing the manufacturing container in a state where the manufacturing container is filled with a gas.
- Step [S 4 ] is a step of vibrating the manufacturing container at a predetermined number of revolution such that the aqueous liquid repeatedly collides with the inner surface of the container.
- Step [S 5 ] is a step of allowing the manufacturing container to stand.
- an aqueous liquid 10 is prepared.
- the aqueous liquid 10 include water such as distilled water, pure water, ultrapure water, deionized water, and RO water.
- the aqueous liquid 10 may contain a small amount of alcohols.
- a manufacturing container 20 (bubble manufacturing container of the present embodiment) is prepared.
- the manufacturing container 20 includes a container body 21 accommodating the aqueous liquid 10 , and a lid 22 for sealing the container body 21 .
- the container body 21 is not particularly limited, but preferably has a bottomed cylindrical shape as shown in FIG. 2( a ) .
- a vial having a volume of about 0.5 to 20 ml is used as the container body 21 .
- a vial having a small volume is used as the container body 21 .
- bubbles 1 having a uniform diameter (size) can be stably obtained.
- a liquid containing the bubbles 1 (hereinafter, simply referred to as “bubble-containing liquid”) having a volume of about 0.3 to 0.6 ml, which is a volume necessary for a single session of ultrasonic diagnosis, can be manufactured.
- bubble-containing liquid a liquid containing the bubbles 1 having a volume of about 0.3 to 0.6 ml, which is a volume necessary for a single session of ultrasonic diagnosis.
- the bubble-containing liquid in the single manufacturing container 20 can be used up, and hence a waste of the manufactured bubbles (bubble-containing liquid) can be eliminated.
- the vial having such a small volume (volume: about 0.5 to 20 ml) has dimensions in which a length X in a longitudinal direction is about 35 to 60 mm and an outer diameter R is about 10 to 40 mm.
- the lid 22 includes a disk-like rubber stopper (septum) 221 that adheres to a vial mouth of the container body 21 and a fastening portion 222 that fixes the rubber stopper 221 to the vial mouth of the container body 21 .
- the rubber stopper 221 is not particularly limited, but for example, a rubber stopper made of silicon can be used.
- the fastening portion 222 is constituted such that it covers the edge of the rubber stopper 221 .
- screw grooves that can be screwed with each other are formed (not shown in the drawing). By screwing the screw grooves with each other, the rubber stopper 221 is fixed to the vial mouth of the container body 21 in a state of adhering to the vial mouth.
- the aqueous liquid 10 is injected into the container body 21 (manufacturing container 20 ) to a predetermined height.
- the aqueous liquid 10 is injected to Y [mm].
- the container body 21 into which the aqueous liquid 10 is injected has a void portion 11 on a top portion thereof.
- the aforementioned X and Y more preferably satisfy a relationship of 0.3 ⁇ Y/X ⁇ 0.5, and even more preferably satisfy a relationship of 0.35 ⁇ Y/X ⁇ 0.4. In this way, in Step [S 4 ], the bubbles 1 can be more easily formed in the aqueous liquid 10 .
- the container body 21 is sealed in a state of being filled with the gas 3 (see FIG. 2( b ) ). Specifically, in the void portion 11 of the container body 21 into which the aqueous liquid 10 is injected, purging is performed using the gas 3 , and then the lid 22 is fastened to an opening portion (vial mouth) of the container body 21 . In this way, the aqueous liquid 10 and the gas 3 are sealed in the manufacturing container 20 .
- the container body 21 into which the aqueous liquid 10 is injected is moved into a chamber. Thereafter, the internal pressure of the chamber is reduced. Then, the gas 3 is injected into the chamber, and in the atmosphere composed of the gas 3 , the lid 22 is fastened to the opening portion of the container body 21 . In this way, the aqueous liquid 10 and the gas 3 can be sealed in the manufacturing container 20 .
- the gas 3 is not particularly limited, and examples thereof include: an inert gas such as air, nitrogen, oxygen, carbon dioxide, hydrogen, helium, argon, xenon, and krypton; sulfur fluoride such as sulfur hexafluoride, disulfur decafluoride, and trifluoromethyl sulfur pentafluoride; low-molecular weight hydrocarbons such as methane, ethane, propane, butane, pentane, cyclopropane, cyclobutane, cyclopentane, ethylene, propylene, propadiene, butene, acetylene, propyne, perfluoropropane, perfluorobutane, and perfluoropentane, or halides thereof; ethers such as dimethyl ether; ketones; esters; and the like. Among these, one kind of substance can be used singly, or two or more kinds of substances can be used in combination.
- an inert gas such as air
- the bubbles 1 constituted with these gases 3 exhibit high stability in the body and are more reliably transported to an affected site (target site of treatment) or a target site of diagnosis through blood vessels.
- the manufacturing container 20 is vibrated such that the aqueous liquid 10 repeatedly collides with the top and bottom surfaces and the lateral surface (particularly, the top and bottom surfaces) of the manufacturing container 20 .
- the manufacturing container 20 is vibrated such that the container reciprocates approximately in the longitudinal direction (a vertical direction in FIG. 2( c ) ) thereof.
- Step [S 3 ] the manufacturing container 20 (lower view in FIG. 2( c ) ) sealed in Step [S 3 ] is vibrated upwardly (middle view in FIG. 2( c ) ).
- the aqueous liquid 10 moves to the vicinity of the middle of the manufacturing container 20 .
- the manufacturing container 20 is further vibrated upwardly, the aqueous liquid 10 moves to the top portion of the manufacturing container 20 and collides with the bottom surface (rubber stopper 221 ) of the lid 22 (upper view in FIG. 2( c ) ).
- shock waves occur.
- the manufacturing container 20 (upper view in FIG. 2( c ) ) is vibrated downwardly (middle view in FIG. 2( c ) ).
- the aqueous liquid 10 moves to the vicinity of the middle of the manufacturing container 20 .
- the aqueous liquid 10 moves to the bottom portion of the manufacturing container 20 and collides with the bottom surface of the manufacturing container 20 (lower view in FIG. 2( c ) ).
- the shock waves also occur.
- the aqueous liquid 10 When the manufacturing container 20 is vibrated in the vertical direction, the aqueous liquid 10 also collides with the inner lateral surface of the manufacturing container 20 . At this time, as shown in FIG. 3 , the shock waves also occur.
- the aqueous liquid 10 and the gas 3 are vibrated (applied with an external force), and due to the pressure of the shock waves that occur due to the vibration, the gas 3 is micro-dispersed in the aqueous liquid 10 .
- a plurality of bubbles 1 constituted with the gas 3 can be generated in the aqueous liquid 10 .
- the manufacturing container 20 is preferably vibrated at the number of revolution of equal to or higher than 5,000 rpm.
- the magnitude (pressure) of the shock waves that occur when the aqueous liquid 10 collides with the manufacturing container 20 becomes high enough, fine bubbles 1 are generated in the aqueous liquid 10 , and the diameter of the bubbles can be made uniform.
- the number of revolution of the manufacturing container 20 is set to be low within the aforementioned range, the magnitude of the occurring shock waves is reduced, and hence the bubbles 1 having a relatively large diameter can be generated.
- the number of revolution is set to be high, the magnitude of the occurring shock waves increases, and hence the bubbles 1 having a relatively small diameter can be generated.
- number of revolution of the manufacturing container 20 refers to the number of times that the manufacturing container 20 travels the whole vibration route thereof per unit time. For example, in a case where the manufacturing container 20 vibrates at 5,000 rpm, it means that the manufacturing container 20 travels (vibrates) in 5,000 times the whole vibration route for 1 minute.
- the number of revolution of the manufacturing container 20 is more preferably equal to or higher than 5,500 rpm, and even more preferably 6,000 to 20,000 rpm. In a case where the number of revolution of the manufacturing container 20 is within the aforementioned range, it is possible to more reliably prevent the bubbles 1 generated by vibration from being destroyed due to collision or from coarsening by being combined with each other. As a result, it is possible to generate a large amount of bubbles 1 having a more uniform diameter in the aqueous liquid 10 with reducing the diameter of the bubbles 1 .
- a bead-type high-speed cell disruption system (homogenizer) can be used.
- Precellys manufactured by bertin Technologies and the like can be used.
- the pressure of the shock waves that occur when the aqueous liquid 10 collides with the manufacturing container 20 is preferably 40 kPa to 1 GPa.
- the pressure of the shock waves that occur at the time of collision between the aqueous liquid 10 and the manufacturing container 20 is within the aforementioned range, the bubbles 1 generated in the aqueous liquid 10 become finer, and the diameter thereof can be made more uniform.
- a vibration width of the manufacturing container 20 in the longitudinal direction is preferably about 0.7 X to 1.5 X [mm], and more preferably about 0.8 X to 1 X [mm].
- the manufacturing container 20 vibrates, it is possible to cause the aqueous liquid 10 to reliably collide with the bottom surface of the manufacturing container 20 and the lid 22 , and to sufficiently increase the number of times that the aqueous liquid 10 collides with the bottom surface of the manufacturing container 20 and the lid 22 .
- the speed at which the aqueous liquid 10 moves in the manufacturing container 20 increases.
- the manufacturing container 20 When the manufacturing container 20 is reciprocated in the vertical direction, the manufacturing container 20 is preferably vibrated in a transverse direction (horizontal direction) thereof as well. In this way, the aqueous liquid 10 also collides with the inner lateral surface of the manufacturing container 20 , and hence more shock waves can be generated in the aqueous liquid 10 .
- the vibration width of the manufacturing container 20 in the transverse direction is preferably about 0.3 X to 0.8 X [mm], and more preferably about 0.5 X to 0.7 X [mm]. In this way, the aforementioned effects are more markedly exhibited.
- the manufacturing container 20 it is preferable to vibrate the manufacturing container 20 such that an instantaneous relative speed between the manufacturing container 20 and the aqueous liquid 10 in the manufacturing container 20 becomes equal to or higher than 40 km/h when the aqueous liquid 10 collides with the top and bottom surfaces and the lateral surface of the manufacturing container 20 . It is more preferable to vibrate the manufacturing container 20 such that the instantaneous relative speed becomes equal to or higher than 50 km/h. In a case where the aforementioned condition is satisfied, it is possible to sufficiently increase the pressure of the shock waves that occur when the aqueous liquid 10 collides with the manufacturing container 20 . As a result, the bubbles 1 generated in the aqueous liquid 10 become finer, and the diameter thereof can be made more uniform.
- the period of time for which the manufacturing container 20 is vibrated under the aforementioned condition is preferably about 10 to 120 seconds, and more preferably about 30 to 60 seconds.
- the vibration time of the manufacturing container 20 is within the aforementioned range, the number of times that the aqueous liquid 10 collides with the manufacturing container 20 sufficiently increases, and hence a large amount of bubbles 1 can be generated in the aqueous liquid 10 .
- the vibration time of the manufacturing container 20 is set to be long within the aforementioned range, the amount of bubbles 1 generated in the aqueous liquid 10 can be further increased.
- the diameter of the bubbles 1 generated in the aqueous liquid 10 can be adjusted by changing a kind and/or an amount of an additive added to the aqueous liquid 10 as will be described later and by changing the number of revolution of the manufacturing container 20 to be within the aforementioned range.
- the bubbles having the diameter of about 10 to 1,000 nm can be stably generated.
- the manufacturing container 20 is vibrated such that the container reciprocates practically in the longitudinal direction thereof, but the method for vibrating the manufacturing container 20 is not limited thereto.
- the manufacturing container 20 may be vibrated such that the container rotates mainly in the transverse direction and/or the longitudinal direction thereof. Even in this case, the aqueous liquid 10 in the manufacturing container 20 repeatedly collides with the top and bottom surfaces and the lateral surface of the manufacturing container 20 , and as a result, the shock waves occur.
- a large amount of bubbles 1 having a uniform diameter can also be stably generated in the aqueous liquid 10 .
- the manufacturing container 20 After the manufacturing container 20 is vibrated under the aforementioned conditions, the manufacturing container 20 is allowed to stand (see FIG. 2( d ) ). In this way, the large amount of bubbles 1 having the uniform diameter can be stably manufactured in the manufacturing container 20 .
- Step [S 2 ], Step [S 3 ], and Step [S 4 ] by making the temperature of the aqueous liquid 10 remain constant.
- the characteristics (viscosity and the like) of the aqueous liquid 10 are stabilized in the manufacturing process of the bubbles, and hence the bubbles 1 having the uniform diameter can be stably generated in the aqueous liquid 10 .
- Examples of the method for making the temperature of the aqueous liquid 10 remain constant include a method of performing each of the aforementioned Steps [S 2 ] to [S 4 ] in a glove box or a thermostatic bath.
- the manufacturing container 20 is vibrated at a high speed in Step [S 4 ]. Therefore, due to the collision between the aqueous liquid 10 and the inner surface of the manufacturing container 20 , the manufacturing container 20 easily heated. However, by vibrating the manufacturing container 20 in the thermostatic bath, it is possible to reliably prevent the temperature increase of the aqueous liquid 10 . As a result, the bubbles 1 having the uniform diameter can be stably generated in the aqueous liquid 10 .
- the bubbles 1 having the diameter of about 10 to 1,000 nm are manufactured. It is considered that due to a cluster structure of water molecules existing on the surface (gas-liquid interface between the gas 3 and the aqueous liquid 10 ) of the bubbles 1 , the bubbles 1 may be stabilized.
- the cluster structure of water molecules is mainly constituted with the water molecules and contains a small amount of hydrogen ions (H + ) and hydroxide ions (OH ⁇ ) which occur due to the ionization of some of the water molecules.
- the bubbles 1 are charged due to the influence of the ions (particularly, hydroxide ions). It is considered that, as a result, the bubbles 1 may be prevented from being combined with each other due to an electric repulsive force, and hence each of the bubbles 1 may be stabilized.
- the inventor of the present invention considered that due to the existence of a certain molecule, ion, radical, or the like on the surfaces of the bubbles 1 , the hardness of the bubbles 1 may be improved. Based on this idea, the inventor repeated an experiment of adding various additives to the aqueous liquid 10 when manufacturing the bubbles 1 . As a result, as the inventor anticipated, the stability (storage stability) of the bubbles 1 tended to be improved. However, unexpectedly, it was revealed that even if the manufacturing condition (for example, an amount of the additives, the number of revolution of the manufacturing container 20 , or the like) is the same, bubbles 1 having different diameters (average diameters) are generated according to a kind of the additive. Furthermore, it was also revealed that even if the same additive is used, the bubbles 1 having the different diameters (average diameters) are generated according to the amount of the additive added.
- the manufacturing condition for example, an amount of the additives, the number of revolution of the manufacturing container 20 , or the like
- the inventor of the present invention completed the method for manufacturing bubbles of the present invention. That is, in the method for manufacturing bubbles of the present invention, by changing the kind and/or amount of the additive added to the aqueous liquid 10 , the diameter of the generated bubbles 1 is adjusted.
- the additive added to the aqueous liquid 10 preferably includes at least one kind of additive among a protein, salts, and sugars.
- the bubbles 1 can be more reliably stabilized.
- the generated bubbles 1 are constituted with the gas 3 , and it is considered that either or both of a molecule of the additive and a component (for example, an ion, a radical, and the like) derived from the additive may be adsorbed onto (exist on) a portion of the surfaces (gas-liquid interface) of the bubbles 1 . That is, it is considered that the surfaces of the bubbles 1 may be incompletely covered with the molecule of the additive and/or the component derived from the additive.
- a component for example, an ion, a radical, and the like
- Examples of the protein include albumin, globulin, and the like.
- Examples of the salts include NaCl, KC 1 , Na 2 HPO 4 , KH 2 PO 4 , C 3 H 5 NaO 3 , and the like.
- Examples of the sugars include glucose, sucrose, dextrin, and the like.
- aqueous liquid 10 to which the salts are added for example, physiological saline (0.9 w/v % aqueous NaCl solution) and phosphate buffered saline (PBS) can be used.
- physiological saline 0.9 w/v % aqueous NaCl solution
- PBS phosphate buffered saline
- the aqueous liquid 10 to which the salts and sugars are added for example, Nos. 1 to 4 infusion solutions (electrolyte solutions) can be used.
- an albumin preparation, a globulin preparation, and the like can be used. These are on the market as preparations. Therefore, by using these as they are, it is possible to simplify the manufacturing process of the bubbles 1 and reduce the manufacturing costs.
- the amount of the additive added to the aqueous liquid 10 is preferably about 0 to 50 w/v %, more preferably about 0.1 to 40 w/v %, even more preferably about 0.5 to 30 w/v %, and particularly preferably about 1 to 20 w/v %.
- the amount of the additive added to the aqueous liquid 10 is set to be within the aforementioned range, highly stable bubbles 1 having the more uniform diameter can be manufactured, although manufacturing of such bubbles 1 also depends on the kind of the additive.
- the method for manufacturing bubbles described above it is possible to easily manufacture the large amount of bubbles 1 without requiring a large-scale system. Furthermore, because the sealed container (airtight container) is used for manufacturing the bubbles 1 , in a case where the manufacturing container is filled with the aqueous liquid 10 and the gas 3 and then the interior of the container is subjected to a sterilization treatment such as ⁇ -ray sterilization, the bubbles 1 can be manufactured in a sterile environment. Accordingly, the bubbles 1 manufactured in this way can be suitably used in the field of food or medical care.
- the bubbles 1 obtained as above can stably exist in the aqueous liquid 10 . Therefore, the sealed container containing the obtained bubbles 1 can be stored for a long period of time, such as 6 to 24 months, at room temperature. Furthermore, even after the container is stored for such a long period of time, the number of bubbles 1 in the aqueous liquid 10 substantially is not reduced. Therefore, the sealed container does not need to be vibrated again before use. Accordingly, the sealed container containing the bubbles 1 is easily handled in medical facilities and the like. In addition, because the sealed container having a small volume can be used, the unit cost of the sealed container can be reduced.
- the obtained bubbles 1 (bubble-containing liquid) are used for making an ultrasonic diagnosis for patients.
- an injection needle of a syringe is pierced into the rubber stopper of the sealed container. Then, the bubble-containing liquid is aspirated into the syringe from the interior of the sealed container. Thereafter, the injection needle is pulled out of the rubber stopper, and a blood vessel (for example, a vein) of a patient is pierced by the injection needle such that the bubble-containing liquid is injected into the blood vessel. In this way, the bubbles 1 are transported to the affected site (target site of diagnosis) through the blood flow.
- a blood vessel for example, a vein
- the bubbles 1 are irradiated with ultrasonic waves for diagnosis having a frequency and an intensity at which the bubbles 1 may not burst (the ultrasonic waves are radiated to the bubbles 1 ). Then, the signals (reflection echo) reflected from the target site of diagnosis are received and subjected to data processing, thereby imaging the target site of diagnosis. In this way, an ultrasonic diagnosis can be made.
- known ultrasonic probes can be used as a device performing the irradiation of the ultrasonic waves and receiving the reflection waves from the bubbles 1 .
- the bubbles 1 can be used in various fields, in addition to being used for the ultrasonic diagnosis.
- the bubbles 1 exhibit a germicidal effect with respect to water or food and have an effect of keeping the freshness of food.
- an aqueous liquid containing the bubbles 1 water, and oil (hydrophobic component), a large amount of oil can be mixed with water. By exploiting such an effect, it is possible to cook with inhibiting the separation of water from oil in food. Accordingly, the bubble-containing liquid containing the bubbles 1 can also be used in the field of food.
- the bubbles 1 have the diameter of about 10 to 1,000 nm.
- the bubbles 1 having the diameter within the above range are injected into the blood vessel by the injection, the bubbles are smoothly transported in the blood vessel due to the blood flow.
- the bubbles 1 (nanobubbles) having the diameter of about 200 to 300 nm are highly stable in a blood vessel. Therefore, such bubbles are reliably transported to a target site practically without being destroyed.
- bubbles constituted with a gas have a property of efficiently reflecting the ultrasonic waves from an interface between a liquid and a gas. Therefore, in the bubbles 1 having the diameter within the aforementioned range, an area of the interface between the gas 3 and the aqueous liquid 10 is large enough, and hence the bubbles 1 are effectively used as an ultrasound contrast agent. Particularly, the nanobubbles exhibit sufficiently high stability. Therefore, the nanobubbles can be used as the ultrasound contrast agent and actively used in various fields described above.
- neovessels having a diameter smaller than that of a normal blood vessel extend to the cancer cell from the normal blood vessels around the affected site.
- the nanobubbles can be smoothly transported even in the neovessels and can reach the cancer cell. Then, by irradiating the bubbles 1 with the therapeutic ultrasonic waves having a frequency and intensity at which the bubbles can burst, it is possible to induce death of the cancer cell. That is, the nanobubbles can be suitably used for cancer treatment. Furthermore, some of the nanobubbles can be passed through the wall of the blood vessel and incorporated into the cancer cell.
- the bubbles 1 having the diameter of about 600 to 900 nm can be smoothly transported in blood vessels in the brain, and a position thereof can be clearly specified in an ultrasonic image. Therefore, the bubbles 1 can be suitably used in brain treatment (for example, endovascular treatment of brain).
- the diameter (average diameter) of the bubbles 1 can be measured by observation using, for example, a laser diffraction-scattering method, a nanoparticle tracking analysis method, an electric resistance method, an atomic force microscope (AFM), a laser microscope, and the like.
- a device for measuring by AFM for example, it is possible to use a resonant particle measurement system (trade name: ARCHIMEDES) manufactured by Malvern Instruments Ltd.
- ARCHIMEDES resonant particle measurement system manufactured by Malvern Instruments Ltd.
- Steps [S 1 ] to [S 5 ] by performing Steps [S 1 ] to [S 5 ], the large amount of bubbles 1 having the uniform diameter can be stably manufactured in the manufacturing container 20 .
- Steps [S 4 ] and [S 5 ] may be repeated, and in this way, the bubbles 1 having the more uniform diameter can be stably generated.
- FIG. 4 is a flow chart for illustrating the second embodiment of the method for manufacturing bubbles of the present invention.
- FIGS. 5( a ) to 5( d ) are views (cross-sectional views of a bubble manufacturing container) for illustrating the second embodiment of the method for manufacturing bubbles of the present invention.
- FIGS. 5( a ) to 5( d ) the upper side in each of FIGS. 5( a ) to 5( d ) will be referred to as “top”, and the lower side in each of FIGS. 5( a ) to 5( d ) will be referred to as “bottom”.
- the method for manufacturing bubbles of the present embodiment is the same as the method for manufacturing bubbles of the first embodiment described above, except that as shown in FIG. 4 , in Step [S 3 ] of the first embodiment, the manufacturing container 20 is filled with the gas 3 and sealed in a state where the interior of the manufacturing container 20 is pressurized.
- the aqueous liquid 10 and the manufacturing container 20 of the first embodiment described above are prepared.
- the aqueous liquid 10 is injected into the manufacturing container 20 .
- the container body 21 is filled with the gas 3 and sealed in a state where the interior of the manufacturing container 20 is pressurized (see FIG. 5( b ) ). Specifically, by using the gas 3 , purging is performed in the void portion 11 of the container body 21 into which the aqueous liquid 10 is injected, and then the lid 22 is fastened to the opening portion (vial mouth) of the container body 21 . In this way, the aqueous liquid 10 and the gas 3 are sealed in the manufacturing container 20 .
- a syringe filled with the gas 3 is prepared, and an injection needle of the syringe is pierced into the rubber stopper 221 .
- the gas 3 is further added into the manufacturing container 20 from the syringe, thereby pressurizing the interior of the manufacturing container 20 .
- the injection needle is pulled out of the rubber stopper 221 . In this way, it is possible to obtain the manufacturing container 20 which is sealed in a state where the interior thereof is pressurized due to the gas 3 .
- the manufacturing container 20 is vibrated such that the aqueous liquid 10 repeatedly collides with the top and bottom surfaces and the lateral surface of the manufacturing container 20 .
- the manufacturing container 20 is allowed to stand.
- Step [S 3 ] the interior of the manufacturing container 20 is caused to be in the state of being pressurized due to the gas 3 , and in this way, a portion of the gas 3 is in a state of being micro-dispersed or dissolved in the aqueous liquid 10 . Accordingly, in Step [S 4 ], the bubbles 1 easily occur in the aqueous liquid 10 , and hence more bubbles 1 having the uniform size can be manufactured than in the method for manufacturing bubbles of the first embodiment described above. Furthermore, the bubbles 1 having a diameter smaller than in the first embodiment can be generated.
- the internal pressure (pressure of the gas 3 with which the void portion 11 is filled) of the manufacturing container 20 in Step [S 3 ] is preferably higher than 1.0 atm, more preferably 1.5 to 10 atm, and even more preferably 2 to 5 atm. In this way, a large amount of gas 3 can be micro-dispersed or dissolved in the aqueous liquid 10 .
- FIG. 6 is a flow chart for illustrating the third embodiment of the method for manufacturing bubbles of the present invention.
- the method for manufacturing bubbles of the present embodiment includes, after Steps [S 1 ] to [S 5 ] of the first embodiment described above, Step [S 6 ] and Step [S 7 ].
- Step [S 6 ] is a step of changing the internal pressure of the manufacturing container.
- Step [S 7 ] is a step of setting the number of revolution at which the manufacturing container is vibrated.
- the method for manufacturing bubbles of the present embodiment further includes Step [S 4 ′] and Step [S 5 ′].
- the method for manufacturing bubbles of the present embodiment further includes Step [S 8 ] and Step [S 9 ].
- the method for manufacturing bubbles of the present embodiment includes Step [S 10 ] of changing the internal pressure of the manufacturing container.
- the interior of the manufacturing container 20 is pressurized in the same manner as in the aforementioned Step [S 3 ].
- the gas 3 to be injected may be the same as or different from the gas 3 used in Step [S 3 ]. However, from the viewpoint of the stability of the finally generated bubbles, it is preferable to use the same gas 3 .
- the internal pressure of the manufacturing container 20 is further increased compared to the internal pressure of the manufacturing container 20 in Step [S 3 ]. Therefore, the amount of the gas 3 which is micro-dispersed or dissolved in the aqueous liquid 10 becomes larger than the amount of the gas 3 which is micro-dispersed or dissolved in the aqueous liquid 10 in Step [S 3 ]. Consequently, when the manufacturing container 20 is vibrated again in Step [S 4 ′] or Step [S 8 ] which will be described later, the bubbles 1 are more easily generated, and as a result, the amount of the generated bubbles 1 increases.
- the internal pressure of the manufacturing container 20 is higher than the pressure in Step [S 3 ] preferably by 0 . 5 atm or more, and more preferably by 1 to 10 atm. In this way, it is possible to more reliably generate the bubbles 1 having a diameter smaller than that of the bubbles 1 generated in Step [S 4 ] described above.
- an empty syringe is prepared, and then an injection needle of the syringe is pierced into the rubber stopper 221 . Thereafter, the gas 3 in the manufacturing container 20 is aspirated into the syringe. In this way, the internal pressure of the manufacturing container 20 is reduced. Then, the injection needle is pulled out of the rubber stopper 221 .
- the internal pressure of the manufacturing container 20 is appropriately adjusted within such a range that the internal pressure becomes higher than 1.0 atm but is lower than the pressure in Step [S 3 ].
- the number of revolution at the time of vibrating again the container is set to be equal to or higher than 5 , 000 rpm.
- Step [S 7 ] in a case where the number of revolution at the time of vibrating again the manufacturing container 20 is not changed from the number of revolution in Step [S 4 ], that is, in a case where “NO” is selected in Step [S 7 ] in FIG. 6 , the following Step [S 4 ′] is performed.
- Step [S 7 ] in a case where the number of revolution at the time of vibrating again the manufacturing container 20 is changed from the number of revolution in Step [S 4 ], that is, in a case where “YES” is selected in Step [S 7 ] in FIG. 6 , the following Step [S 8 ] is performed.
- the manufacturing container 20 whose internal pressure is changed is vibrated again at the same number of revolution as in Step [S 4 ] described above.
- the bubbles 1 having a diameter different from that of the bubbles 1 generated in Step [S 4 ] are generated in the aqueous liquid 10 .
- the manufacturing container 20 is vibrated again at the same number of revolution as in Step [S 4 ]. Therefore, the diameter of the bubbles 1 newly generated in the present embodiment changes according to the pressure changed in Step [S 6 ]. That is, by changing the pressure, the diameter of the bubbles 1 can be adjusted. Consequently, according to the change of the kind and/or amount of the additive added to the aqueous liquid, the bubbles 1 having different intended diameters (average diameters) can be manufactured with excellent reproducibility. Furthermore, because the setting of a device vibrating the manufacturing container 20 does not need to be changed, the bubbles 1 having the different diameters can be manufactured in a simpler manner.
- the manufacturing container 20 After the manufacturing container 20 is vibrated under the aforementioned condition, the manufacturing container 20 is allowed to stand in the same manner as in Step [S 5 ]. In this way, the large amount of bubbles 1 having the different sizes can be stably manufactured in the manufacturing container 20 .
- Step [S 10 ] is performed.
- the manufacturing container 20 whose internal pressure is changed is vibrated again at the number of revolution different from that in Step [S 4 ] described above. In this way, the bubbles 1 having a diameter different from that of the bubbles 1 generated in Step [S 4 ] are generated in the aqueous liquid 10 .
- the manufacturing container 20 is vibrated again in the same manner as in Step [S 4 ] described above, except that the number of revolution at which the manufacturing container 20 is vibrated is made higher than the number of revolution in Step [S 4 ].
- the number of revolution of the manufacturing container 20 is not particularly limited as long as it is higher than the number of revolution in Step [S 4 ].
- the number of revolution in this case is preferably 6,000 to 20,000 rpm, and more preferably 7,000 to 20,000 rpm.
- the manufacturing container 20 is vibrated at the number of revolution higher than that in Step [S 4 ]
- the number of revolution of the manufacturing container 20 by setting the number of revolution of the manufacturing container 20 within the aforementioned range, it is possible to more reliably prevent the bubbles 1 generated in Step [S 4 ] and the present step from being destroyed due to collision or from coarsening by being combined with each other.
- the manufacturing container 20 is vibrated again in the same manner as in Step [S 4 ], except that the number of revolution at which the manufacturing container 20 is vibrated is made lower than that in Step [S 4 ].
- the number of revolution of the manufacturing container 20 is not particularly limited as long as it is lower than the number of revolution in Step [S 4 ].
- the number of revolution in this case is preferably 5,000 to 9,000 rpm, and more preferably 5,500 to 7,500 rpm.
- the manufacturing container 20 is vibrated at the number of revolution lower than that in Step [S 4 ], and hence the bubbles 1 having a diameter larger than that of the bubbles 1 generated in Step [S 4 ] can be generated.
- the number of revolution of the manufacturing container 20 is set to be within the aforementioned range, it is possible to more reliably prevent the bubbles 1 generated in Step [S 4 ] and the present step from being destroyed due to the collision or from coarsening by being combined with each other. As a result, it is possible to manufacture the bubbles 1 generated in Step [S 4 ] and the bubbles 1 having a diameter larger than that of the bubbles 1 generated in Step [S 4 ].
- the manufacturing container 20 is vibrated again at the number of revolution different from that in Step [S 4 ]. Therefore, the diameter of the bubbles 1 newly generated in the present embodiment changes according to the change of the internal pressure of the manufacturing container 20 and to the number of revolution at the time of vibrating again the container. In this way, by changing both the internal pressure of the manufacturing container 20 and the number of revolution at the time of vibrating again the container, it is possible to generate the bubbles 1 having a diameter greatly different from the diameter obtained in the second embodiment described above. Accordingly, in a case where the bubbles 1 that greatly differ from each other in terms of the average diameter are manufactured, the present step is advantageous.
- Step [S 9 ] Step of allowing manufacturing container to stand After the manufacturing container 20 is vibrated in Step [S 8 ], the manufacturing container 20 is allowed to stand in the same manner as in Step [S 5 ]. In this way, the bubbles 1 having the different diameters can be stably manufactured in the manufacturing container 20 .
- Step [S 10 ] is performed.
- Step [S 10 ] in FIG. 6 the method for manufacturing bubbles of the present embodiment is finished.
- two kinds of bubbles 1 first bubbles and second bubbles having different average diameters within a range of 10 nm to 1 , 000 nm are manufactured.
- Step [S 7 ] is performed. Then, Steps [S 4 ′], [S 5 ′], and [S 10 ] described above or Steps [S 8 ], [S 9 ], and [S 10 ] are repeated. In this way, it is possible to manufacture the bubbles 1 having a plurality of different average diameters within a range of 10 nm to 1,000 nm.
- Step [S 10 ] it is possible to manufacture the bubbles 1 having the plurality of different average diameters according to the number of times the pressure is changed.
- the bubble-containing liquid is obtained which contains the bubbles 1 having the different diameters in the aqueous liquid 10 .
- the ease of passing the bubbles 1 in blood vessels and the site to which the bubbles are transported vary with the difference in the size (for example, the smaller the diameter of the bubbles 1 is, the farther the bubbles 1 can be transported toward the end of a capillary). Therefore, the bubble-containing liquid obtained as above can be used in many ways according to the purpose of the ultrasonic diagnosis and/or the ultrasound therapy.
- Frist 12 ml of distilled water (aqueous liquid) was prepared, and a 15 ml vial (height X: 50 mm, outer diameter R: 25 mm) was prepared.
- the vial had the same shape as that of the manufacturing container 20 shown in FIG. 2 .
- the distilled water was injected into the prepared vial.
- a height Y of a surface of the distilled water was 25 mm.
- the sealed vial was vibrated for 30 seconds at the number of revolution of 6,500 rpm. At this time, the sealed vial was caused to reciprocate up and down, and it was confirmed that the distilled water repeatedly collides with the top and bottom surfaces of the sealed vial.
- a vibration width of the sealed vial was set to be 40 mm in a vertical direction and 20 mm in a horizontal direction, such that an instantaneous relative speed between vial and the distilled water became equal to or higher than 40 km/h.
- the sealed vial was allowed to stand, thereby obtaining a bubble-containing liquid containing bubbles constituted with perfluoropropane in the distilled water.
- Bubbles were generated and a bubble-containing liquid was manufactured in the same manner as in Example 1, except that the distilled water was changed to a 1 w/v % aqueous dextrin solution.
- Bubbles were generated and a bubble-containing liquid was manufactured in the same manner as in Example 1, except that the distilled water was changed to PBS.
- Bubbles were generated and a bubble-containing liquid was manufactured in the same manner as in Example 1, except that the distilled water was changed to a SOLDEM 3 A infusion solution (manufactured by Terumo Corporation).
- Bubbles were generated and a bubble-containing liquid was manufactured in the same manner as in Example 1, except that the distilled water was changed to a SOLDEM 1 infusion solution (manufactured by Terumo Corporation).
- Bubbles were generated and a bubble-containing liquid was manufactured in the same manner as in Example 1, except that the distilled water was changed to physiological saline (0.9 w/v % aqueous NaCl solution).
- Bubbles were generated and a bubble-containing liquid was manufactured in the same manner as in Example 1, except that the distilled water was changed to a 0.25 w/v % aqueous albumin solution.
- Bubbles were generated and a bubble-containing liquid was manufactured in the same manner as in Example 1, except that the distilled water was changed to a 20 w/v % aqueous glucose solution.
- Bubbles were generated and a bubble-containing liquid was manufactured in the same manner as in Example 1, except that the distilled water was changed to a 5 w/v % aqueous glucose solution.
- Bubbles were generated and a bubble-containing liquid was manufactured in the same manner as in Example 1, except that the distilled water was changed to a 10 w/v % aqueous glucose solution.
- Bubbles were generated and a bubble-containing liquid was manufactured in the same manner as in Example 1, except that the distilled water was changed to a 40 w/v % aqueous glucose solution.
- Bubbles were generated and a bubble-containing liquid was manufactured in the same manner as in Example 1, except that the distilled water was changed to a 50 w/v % aqueous glucose solution.
- the bubble-containing liquid obtained as above was set in a bubble measurement device (nanoparticle analysis system nanosight), and diameter distributions of the bubbles contained in the bubble-containing liquid (aqueous liquid) was measured.
- FIGS. 7 and 8 show results.
- the diameter of the generated bubbles changes depending on whether or not an additive is added to the aqueous liquid. Furthermore, it is understood that the diameter of the generated bubbles also varies with the kind and amount of the additive added to the aqueous liquid.
- the diameter of the generated bubbles tends to increase. Furthermore, even in a case where the bubbles are manufactured in the same manner as in the third embodiment, according to the kind and/or amount of the additive added to the aqueous liquid, the diameter of the generated bubbles could change.
- the method for manufacturing bubbles of the present invention may additionally include one or more steps for a certain purpose.
- Step [S 4 ] of the embodiments described above by supplying the ultrasonic waves to the aqueous liquid 10 and the gas 3 , vibration (external force) may be caused.
- the ultrasonic waves preferably have a frequency of about 20 kHz to 10 MHz (particularly, about 200 kHz to 1 MHz) and an intensity of about 10 mW/cm 2 to 1,000 mW/cm 2 (particularly, about 100 mW/cm 2 to 100 W/cm 2 ).
- the method for manufacturing bubbles of the present invention includes a step of mixing an aqueous liquid with a gas with applying an external force to the aqueous liquid and the gas such that a plurality of bubbles constituted with the gas are generated in the aqueous liquid, in which in this step, a diameter of the bubbles generated is adjusted by changing a kind and/or an amount of an additive added to the aqueous liquid.
- a diameter of the bubbles generated is adjusted by changing a kind and/or an amount of an additive added to the aqueous liquid.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Radiology & Medical Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Pharmacology & Pharmacy (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Mechanical Engineering (AREA)
- Acoustics & Sound (AREA)
- Medical Informatics (AREA)
- Surgery (AREA)
- Biophysics (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Mixers With Rotating Receptacles And Mixers With Vibration Mechanisms (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
- Accessories For Mixers (AREA)
- Surgical Instruments (AREA)
- Ultra Sonic Daignosis Equipment (AREA)
- Medicinal Preparation (AREA)
- Closures For Containers (AREA)
Abstract
A method, for manufacturing bubbles of the present invention includes: mixing and aqueous liquid 10 with a gas 3; and applying vibration (an external force) to the aqueous liquid 10 and the gas 3 to generate a plurality of bubbles 1 constituted with the gas in the aqueous liquid 10. A diameter of the bubbles 1 to be generated in adjusted by changing a kind and/or an amount of an additive to be added to the aqueous liquid 10. In this way, it is possible to provide a method for manufacturing bubbles that makes it possible to wasily and reliably adjust the diameter of the bubbles to be generated. The additive to be added to the aqueous liquid 10 includes at least on kind of additive among a protein, salts, and sugars.
Description
- The present invention relates to a method for manufacturing bubbles.
- In recent years, in the various fields such as medical care, food, seafood farming, and waste water treatment, the use of micro-sized (about hundreds of micrometers) or nano-sized (about hundreds of nanometers) bubbles has been examined. Generally, the bubbles are constituted with an outer shell, which is constituted with a protein, a lipid, or the like, and a gas sealed in the outer shell.
- Particularly, in the medical field, an ultrasonic diagnosis is known which is for making a diagnosis for target site of diagnosis such as chest or abdomen by using such bubbles as an ultrasound contrast agent. During the ultrasonic diagnosis, a diagnosis is made by injecting the bubbles into a blood vessel, irradiating the target site of the diagnosis where the bubbles gather with ultrasonic waves, and making reflected waves (reflection echo) from the target site of the diagnosis into an image.
- In recent years, ultrasound therapy using bubbles has been examined (for example, PTL 1). During the ultrasound therapy, bubbles in which a gene or a medical agent (drug) is sealed are injected into a blood vessel and transported to an affected site through the blood flow. When the bubbles reach the vicinity of the affected site, ultrasonic waves are radiated to the bubbles such that the bubbles burst. In this way, the drug sealed in the bubbles can be selectively supplied to the affected site.
- As methods for manufacturing the bubbles, a supersaturation bubble generation method and a gas-liquid two-phase flow swirling method are known. The supersaturation bubble generation method is a method in which a gas is dissolved under a high pressure in a mixed liquid containing constituent materials of the bubbles and physiological saline, and then the pressure is reduced such that the bubbles are generated in the mixed liquid. The gas-liquid two-phase flow swirling method is a method in which the aforementioned mixed liquid is stirred at a high speed such that the mixed liquid swirls, a gas is allowed to sufficiently drawn into the swirl, and then the occurrence of swirl is stopped such that the bubbles are generated in the mixed liquid.
- However, in the above methods, in order to manufacture bubbles having an intended size, a bubble manufacturing condition needs to be strictly controlled. Furthermore, even if the bubble manufacturing condition is strictly set, the size of the generated bubbles easily changes due to external factors, and it is extremely difficult to control the size of the bubbles.
- [PTL 1] JP-A-2002-209896
- An object of the present invention is to provide a method for manufacturing bubbles that makes it possible to easily and reliably adjust a diameter (size) of generated bubbles.
- The aforementioned object is achieved by the present invention described below in (1) to (10).
- (1) A method for manufacturing bubbles, including
-
- mixing an aqueous liquid with a gas; and
- applying an external force to the aqueous liquid and the gas to generate a plurality of bubbles constituted with the gas in the aqueous liquid,
- wherein a diameter of the bubbles to be generated is adjusted by changing a kind and/or an amount of an additive to be added to the aqueous liquid.
- (2) The method for manufacturing bubbles described in (1),
-
- wherein the additive to be added to the aqueous liquid includes at least one kind of additive among a protein, salts, and sugars.
- (3) The method for manufacturing bubbles described in (1) or (2),
-
- wherein the amount of the additive added to the aqueous liquid is in the range of 0 to 50 w/v %.
- (4) The method for manufacturing bubbles described in any one of (1) to (3),
-
- wherein in a case where the additive is added to the aqueous liquid, a molecule of the additive and/or a component derived from the additive exist in a portion of a gas-liquid interface which is a surface of each of the bubbles and is between the gas and the aqueous liquid.
- (5) The method for manufacturing bubbles described in any one of (1) to (4),
-
- wherein the external force is vibration.
- (6) The method for manufacturing bubbles described in (5),
-
- wherein the aqueous liquid and the gas are added into a container, and
- the container is vibrated such that the aqueous liquid repeatedly collides with an inner surface of the container.
- (7) The method for manufacturing bubbles described in (6),
-
- wherein the container has a long shape and is vibrated to reciprocate in a longitudinal direction of the container and/or rotate mainly in the longitudinal direction.
- (8) The method for manufacturing bubbles described in (6) or (7),
-
- wherein the container has a long shape and is vibrated to reciprocate in a transverse direction of the container and/or rotate mainly in the transverse direction.
- (9) The method for manufacturing bubbles described in any one of (6) to (8),
-
- wherein the container is vibrated in a state where an internal pressure of the container is higher than 1.0 atm.
- (10) The method for manufacturing bubbles described in any one of (6) to (9),
-
- wherein the container is vibrated at a number of revolution of equal to or higher than 5,000 rpm.
- According to the present invention, by a simple operation of changing a kind (type) and/or an amount of additive added to an aqueous liquid, a diameter of the generated bubbles can be reliably adjusted.
-
FIG. 1 is a flow chart for illustrating a method for manufacturing bubbles of the present invention. -
FIG. 2 shows views (cross-sectional views of a bubble manufacturing container) for illustrating the method for manufacturing bubbles of the present invention. -
FIG. 3 is a view for illustrating a state where an aqueous liquid violently collides with an inner surface (top surface) of a container in a step shown inFIG. 2(c) . -
FIG. 4 is a flow chart for illustrating a second embodiment of the method for manufacturing bubbles of the present invention. -
FIG. 5 shows views (cross-sectional views of a bubble manufacturing container) for illustrating the second embodiment of the method for manufacturing bubbles of the present invention. -
FIG. 6 is a flow chart for illustrating a third embodiment of the method for manufacturing bubbles of the present invention. -
FIG. 7 is a graph showing diameter distributions of bubbles obtained in Examples 1 to 8. -
FIG. 8 is a graph showing diameter distributions of bubbles obtained in Examples 8 to 12. - Hereinafter, a method for manufacturing bubbles of the present invention will be described based on suitable embodiments shown in the attached drawings.
- First, a first embodiment of the method for manufacturing bubbles of the present invention will be described.
-
FIG. 1 is a flow chart for illustrating the first embodiment of the method for manufacturing bubbles of the present invention.FIGS. 2(a) to 2(d) are views (cross-sectional views of a bubble manufacturing container) for illustrating the first embodiment of the method for manufacturing bubbles of the present invention.FIG. 3 is a view for illustrating a state where an aqueous liquid violently collides with an inner surface (top surface) of a container in a step shown inFIG. 2(c) . - In the following description, the upper side in each of
FIGS. 2(a) to 2(d) and inFIG. 3 will be referred to as “top”, and the lower side in each ofFIGS. 2(a) to 2(d) and inFIG. 3 will be referred to as “bottom”. - As shown in
FIG. 1 , the method for manufacturing bubbles of the present embodiment includes five steps of Steps [S1] to [S5]. Step [S1] is a step of preparing a bubble manufacturing container (hereinafter, simply referred to as “manufacturing container”) into which the aqueous liquid is injected. Step [S2] is a step of injecting the aqueous liquid into the manufacturing container to a predetermined height. Step [S3] is a step of sealing the manufacturing container in a state where the manufacturing container is filled with a gas. Step [S4] is a step of vibrating the manufacturing container at a predetermined number of revolution such that the aqueous liquid repeatedly collides with the inner surface of the container. Step [S5] is a step of allowing the manufacturing container to stand. - Hereinafter, these steps will be sequentially described.
- [S1] Preparation Step
- First an
aqueous liquid 10 is prepared. Examples of theaqueous liquid 10 include water such as distilled water, pure water, ultrapure water, deionized water, and RO water. Theaqueous liquid 10 may contain a small amount of alcohols. - Then, a manufacturing container 20 (bubble manufacturing container of the present embodiment) is prepared.
- The
manufacturing container 20 includes acontainer body 21 accommodating theaqueous liquid 10, and alid 22 for sealing thecontainer body 21. - The
container body 21 is not particularly limited, but preferably has a bottomed cylindrical shape as shown inFIG. 2(a) . - In the present embodiment, as the
container body 21, a vial having a volume of about 0.5 to 20 ml is used. In the method for manufacturing bubbles, even in a case where such a vial having a small volume is used as thecontainer body 21, when thecontainer body 21 is sealed with thelid 22, because an appropriate pressure is applied to theaqueous liquid 10 in a sealed space within thecontainer body 21, bubbles 1 having a uniform diameter (size) can be stably obtained. - Particularly, in a case where the vial having a volume of about 0.5 to 1.5 ml is used, in a
single manufacturing container 20, a liquid containing the bubbles 1 (hereinafter, simply referred to as “bubble-containing liquid”) having a volume of about 0.3 to 0.6 ml, which is a volume necessary for a single session of ultrasonic diagnosis, can be manufactured. In this case, at the time of the ultrasonic diagnosis, the bubble-containing liquid in thesingle manufacturing container 20 can be used up, and hence a waste of the manufactured bubbles (bubble-containing liquid) can be eliminated. - The vial having such a small volume (volume: about 0.5 to 20 ml) has dimensions in which a length X in a longitudinal direction is about 35 to 60 mm and an outer diameter R is about 10 to 40 mm.
- As shown in
FIGS. 2(b) to 2(d) , thelid 22 includes a disk-like rubber stopper (septum) 221 that adheres to a vial mouth of thecontainer body 21 and afastening portion 222 that fixes therubber stopper 221 to the vial mouth of thecontainer body 21. - The
rubber stopper 221 is not particularly limited, but for example, a rubber stopper made of silicon can be used. - The
fastening portion 222 is constituted such that it covers the edge of therubber stopper 221. On an inner circumferential surface of thefastening portion 222 on the vial mouth side and on an outer circumferential surface of thecontainer body 21 on the vial mouth side, screw grooves that can be screwed with each other are formed (not shown in the drawing). By screwing the screw grooves with each other, therubber stopper 221 is fixed to the vial mouth of thecontainer body 21 in a state of adhering to the vial mouth. Furthermore, by fastening thefastening portion 222 to the vial mouth of thecontainer body 21, it is possible to fix thefastening portion 222 to thecontainer body 21 in a state where therubber stopper 221 adheres to the vial mouth of thecontainer body 21. - [S2] Step of Injecting Aqueous Liquid into Manufacturing Container
- Then, the
aqueous liquid 10 is injected into the container body 21 (manufacturing container 20) to a predetermined height. In the present embodiment, as shown inFIG. 2(a) , theaqueous liquid 10 is injected to Y [mm]. Accordingly, as shown inFIG. 2(a) , thecontainer body 21 into which theaqueous liquid 10 is injected has avoid portion 11 on a top portion thereof. - In the present embodiment, in a state where the container body 21 (manufacturing container 20) into which the
aqueous liquid 10 is injected is allowed to stand horizontally, provided that a height (length in the longitudinal direction) of thecontainer body 21 is X [mm] and the level of a surface of theaqueous liquid 10 in thecontainer body 21 is Y [mm], it is preferable that a relationship of 0.2≦Y/X≦0.7 is satisfied. In a case where the aforementioned relationship is satisfied, due to the existence of thevoid portion 11 that is large enough, in Step [S4], it is possible to make theaqueous liquid 10 more violently collide with the top and bottom surfaces and the lateral surface (particularly, the top and bottom surfaces) of themanufacturing container 20. Due to the collision, shock waves occur in theaqueous liquid 10, and hence thebubbles 1 can be easily formed in theaqueous liquid 10. - The aforementioned X and Y more preferably satisfy a relationship of 0.3≦Y/X≦0.5, and even more preferably satisfy a relationship of 0.35≦Y/X≦0.4. In this way, in Step [S4], the
bubbles 1 can be more easily formed in theaqueous liquid 10. - [S3] Step of Sealing Manufacturing Container
- Then, the
container body 21 is sealed in a state of being filled with the gas 3 (seeFIG. 2(b) ). Specifically, in thevoid portion 11 of thecontainer body 21 into which theaqueous liquid 10 is injected, purging is performed using thegas 3, and then thelid 22 is fastened to an opening portion (vial mouth) of thecontainer body 21. In this way, theaqueous liquid 10 and thegas 3 are sealed in themanufacturing container 20. - More specifically, the
container body 21 into which theaqueous liquid 10 is injected is moved into a chamber. Thereafter, the internal pressure of the chamber is reduced. Then, thegas 3 is injected into the chamber, and in the atmosphere composed of thegas 3, thelid 22 is fastened to the opening portion of thecontainer body 21. In this way, theaqueous liquid 10 and thegas 3 can be sealed in themanufacturing container 20. - The
gas 3 is not particularly limited, and examples thereof include: an inert gas such as air, nitrogen, oxygen, carbon dioxide, hydrogen, helium, argon, xenon, and krypton; sulfur fluoride such as sulfur hexafluoride, disulfur decafluoride, and trifluoromethyl sulfur pentafluoride; low-molecular weight hydrocarbons such as methane, ethane, propane, butane, pentane, cyclopropane, cyclobutane, cyclopentane, ethylene, propylene, propadiene, butene, acetylene, propyne, perfluoropropane, perfluorobutane, and perfluoropentane, or halides thereof; ethers such as dimethyl ether; ketones; esters; and the like. Among these, one kind of substance can be used singly, or two or more kinds of substances can be used in combination. - Among these substances, sulfur hexafluoride, perfluoropropane, perfluorobutane, and perfluoropentane are particularly preferable. The
bubbles 1 constituted with thesegases 3 exhibit high stability in the body and are more reliably transported to an affected site (target site of treatment) or a target site of diagnosis through blood vessels. - [S4] Step of Vibrating Manufacturing Container
- Then, the
manufacturing container 20 is vibrated such that theaqueous liquid 10 repeatedly collides with the top and bottom surfaces and the lateral surface (particularly, the top and bottom surfaces) of themanufacturing container 20. In the present embodiment, as shown inFIG. 2(c) , themanufacturing container 20 is vibrated such that the container reciprocates approximately in the longitudinal direction (a vertical direction inFIG. 2(c) ) thereof. - In this step, the manufacturing container 20 (lower view in
FIG. 2(c) ) sealed in Step [S3] is vibrated upwardly (middle view inFIG. 2(c) ). As a result, theaqueous liquid 10 moves to the vicinity of the middle of themanufacturing container 20. In a case where themanufacturing container 20 is further vibrated upwardly, theaqueous liquid 10 moves to the top portion of themanufacturing container 20 and collides with the bottom surface (rubber stopper 221) of the lid 22 (upper view inFIG. 2(c) ). At this time, as shown inFIG. 3 , shock waves occur. - Meanwhile, the manufacturing container 20 (upper view in
FIG. 2(c) ) is vibrated downwardly (middle view inFIG. 2(c) ). As a result, theaqueous liquid 10 moves to the vicinity of the middle of themanufacturing container 20. In a case where themanufacturing container 20 is further vibrated downwardly, theaqueous liquid 10 moves to the bottom portion of themanufacturing container 20 and collides with the bottom surface of the manufacturing container 20 (lower view inFIG. 2(c) ). At this time, as shown inFIG. 3 , the shock waves also occur. - When the
manufacturing container 20 is vibrated in the vertical direction, theaqueous liquid 10 also collides with the inner lateral surface of themanufacturing container 20. At this time, as shown inFIG. 3 , the shock waves also occur. - In this way, while being mixed together, the
aqueous liquid 10 and thegas 3 are vibrated (applied with an external force), and due to the pressure of the shock waves that occur due to the vibration, thegas 3 is micro-dispersed in theaqueous liquid 10. As a result, a plurality ofbubbles 1 constituted with thegas 3 can be generated in theaqueous liquid 10. - By repeating the aforementioned operation, a large amount of
bubbles 1 having a uniform diameter can be stably generated in theaqueous liquid 10. - In the method for manufacturing bubbles, in order to obtain the
bubbles 1 that are fine enough and have the uniform diameter, themanufacturing container 20 is preferably vibrated at the number of revolution of equal to or higher than 5,000 rpm. As a result, the magnitude (pressure) of the shock waves that occur when theaqueous liquid 10 collides with themanufacturing container 20 becomes high enough,fine bubbles 1 are generated in theaqueous liquid 10, and the diameter of the bubbles can be made uniform. In a case where the number of revolution of themanufacturing container 20 is set to be low within the aforementioned range, the magnitude of the occurring shock waves is reduced, and hence thebubbles 1 having a relatively large diameter can be generated. Furthermore, in a case where the number of revolution is set to be high, the magnitude of the occurring shock waves increases, and hence thebubbles 1 having a relatively small diameter can be generated. - In the present specification, “number of revolution” of the
manufacturing container 20 refers to the number of times that themanufacturing container 20 travels the whole vibration route thereof per unit time. For example, in a case where themanufacturing container 20 vibrates at 5,000 rpm, it means that themanufacturing container 20 travels (vibrates) in 5,000 times the whole vibration route for 1 minute. - The number of revolution of the
manufacturing container 20 is more preferably equal to or higher than 5,500 rpm, and even more preferably 6,000 to 20,000 rpm. In a case where the number of revolution of themanufacturing container 20 is within the aforementioned range, it is possible to more reliably prevent thebubbles 1 generated by vibration from being destroyed due to collision or from coarsening by being combined with each other. As a result, it is possible to generate a large amount ofbubbles 1 having a more uniform diameter in theaqueous liquid 10 with reducing the diameter of thebubbles 1. - As a device that can vibrate the
manufacturing container 20 at the number of revolution described above, for example, a bead-type high-speed cell disruption system (homogenizer) can be used. Specifically, Precellys manufactured by bertin Technologies and the like can be used. - The pressure of the shock waves that occur when the
aqueous liquid 10 collides with themanufacturing container 20 is preferably 40 kPa to 1 GPa. In a case where the pressure of the shock waves that occur at the time of collision between theaqueous liquid 10 and themanufacturing container 20 is within the aforementioned range, thebubbles 1 generated in theaqueous liquid 10 become finer, and the diameter thereof can be made more uniform. Particularly, the higher the pressure of the shock waves that occur at the time of collision between theaqueous liquid 10 and themanufacturing container 20 is, the finer the generated bubbles 1 can become. - At the time of vibrating the
manufacturing container 20, a vibration width of themanufacturing container 20 in the longitudinal direction is preferably about 0.7 X to 1.5 X [mm], and more preferably about 0.8 X to 1 X [mm]. In this way, when themanufacturing container 20 vibrates, it is possible to cause theaqueous liquid 10 to reliably collide with the bottom surface of themanufacturing container 20 and thelid 22, and to sufficiently increase the number of times that theaqueous liquid 10 collides with the bottom surface of themanufacturing container 20 and thelid 22. Furthermore, in a case where themanufacturing container 20 is vibrated at the sufficient vibration width described above, the speed at which theaqueous liquid 10 moves in themanufacturing container 20 increases. Therefore, the magnitude of the shock waves that occur when theaqueous liquid 10 collides with the bottom surface of themanufacturing container 20 and thelid 22 sufficiently increases. As a result, it is possible to generate a large amount offine bubbles 1 in theaqueous liquid 10. - When the
manufacturing container 20 is reciprocated in the vertical direction, themanufacturing container 20 is preferably vibrated in a transverse direction (horizontal direction) thereof as well. In this way, theaqueous liquid 10 also collides with the inner lateral surface of themanufacturing container 20, and hence more shock waves can be generated in theaqueous liquid 10. The vibration width of themanufacturing container 20 in the transverse direction is preferably about 0.3 X to 0.8 X [mm], and more preferably about 0.5 X to 0.7 X [mm]. In this way, the aforementioned effects are more markedly exhibited. - In this step, it is preferable to vibrate the
manufacturing container 20 such that an instantaneous relative speed between the manufacturingcontainer 20 and theaqueous liquid 10 in themanufacturing container 20 becomes equal to or higher than 40 km/h when theaqueous liquid 10 collides with the top and bottom surfaces and the lateral surface of themanufacturing container 20. It is more preferable to vibrate themanufacturing container 20 such that the instantaneous relative speed becomes equal to or higher than 50 km/h. In a case where the aforementioned condition is satisfied, it is possible to sufficiently increase the pressure of the shock waves that occur when theaqueous liquid 10 collides with themanufacturing container 20. As a result, thebubbles 1 generated in theaqueous liquid 10 become finer, and the diameter thereof can be made more uniform. - The period of time for which the
manufacturing container 20 is vibrated under the aforementioned condition is preferably about 10 to 120 seconds, and more preferably about 30 to 60 seconds. In a case where the vibration time of themanufacturing container 20 is within the aforementioned range, the number of times that theaqueous liquid 10 collides with themanufacturing container 20 sufficiently increases, and hence a large amount ofbubbles 1 can be generated in theaqueous liquid 10. In a case where the vibration time of themanufacturing container 20 is set to be long within the aforementioned range, the amount ofbubbles 1 generated in theaqueous liquid 10 can be further increased. - The diameter of the
bubbles 1 generated in theaqueous liquid 10 can be adjusted by changing a kind and/or an amount of an additive added to theaqueous liquid 10 as will be described later and by changing the number of revolution of themanufacturing container 20 to be within the aforementioned range. In the present embodiment, by using water as theaqueous liquid 10 as described above, the bubbles having the diameter of about 10 to 1,000 nm can be stably generated. - In the present embodiment, the
manufacturing container 20 is vibrated such that the container reciprocates practically in the longitudinal direction thereof, but the method for vibrating themanufacturing container 20 is not limited thereto. For example, themanufacturing container 20 may be vibrated such that the container rotates mainly in the transverse direction and/or the longitudinal direction thereof. Even in this case, theaqueous liquid 10 in themanufacturing container 20 repeatedly collides with the top and bottom surfaces and the lateral surface of themanufacturing container 20, and as a result, the shock waves occur. By using the aforementioned vibrating method, a large amount ofbubbles 1 having a uniform diameter can also be stably generated in theaqueous liquid 10. - [S5] Step of Allowing Manufacturing Container to Stand
- After the
manufacturing container 20 is vibrated under the aforementioned conditions, themanufacturing container 20 is allowed to stand (seeFIG. 2(d) ). In this way, the large amount ofbubbles 1 having the uniform diameter can be stably manufactured in themanufacturing container 20. - It is preferable to perform the aforementioned Step [S2], Step [S3], and Step [S4] by making the temperature of the
aqueous liquid 10 remain constant. In this way, the characteristics (viscosity and the like) of theaqueous liquid 10 are stabilized in the manufacturing process of the bubbles, and hence thebubbles 1 having the uniform diameter can be stably generated in theaqueous liquid 10. Examples of the method for making the temperature of theaqueous liquid 10 remain constant include a method of performing each of the aforementioned Steps [S2] to [S4] in a glove box or a thermostatic bath. - Particularly, in the present embodiment, the
manufacturing container 20 is vibrated at a high speed in Step [S4]. Therefore, due to the collision between theaqueous liquid 10 and the inner surface of themanufacturing container 20, themanufacturing container 20 easily heated. However, by vibrating themanufacturing container 20 in the thermostatic bath, it is possible to reliably prevent the temperature increase of theaqueous liquid 10. As a result, thebubbles 1 having the uniform diameter can be stably generated in theaqueous liquid 10. - Through Steps [S1] to [S5] described above, the
bubbles 1 having the diameter of about 10 to 1,000 nm are manufactured. It is considered that due to a cluster structure of water molecules existing on the surface (gas-liquid interface between thegas 3 and the aqueous liquid 10) of thebubbles 1, thebubbles 1 may be stabilized. The cluster structure of water molecules is mainly constituted with the water molecules and contains a small amount of hydrogen ions (H+) and hydroxide ions (OH−) which occur due to the ionization of some of the water molecules. Thebubbles 1 are charged due to the influence of the ions (particularly, hydroxide ions). It is considered that, as a result, thebubbles 1 may be prevented from being combined with each other due to an electric repulsive force, and hence each of thebubbles 1 may be stabilized. - The inventor of the present invention considered that due to the existence of a certain molecule, ion, radical, or the like on the surfaces of the
bubbles 1, the hardness of thebubbles 1 may be improved. Based on this idea, the inventor repeated an experiment of adding various additives to theaqueous liquid 10 when manufacturing thebubbles 1. As a result, as the inventor anticipated, the stability (storage stability) of thebubbles 1 tended to be improved. However, unexpectedly, it was revealed that even if the manufacturing condition (for example, an amount of the additives, the number of revolution of themanufacturing container 20, or the like) is the same, bubbles 1 having different diameters (average diameters) are generated according to a kind of the additive. Furthermore, it was also revealed that even if the same additive is used, thebubbles 1 having the different diameters (average diameters) are generated according to the amount of the additive added. - Based on the aforementioned results, the inventor of the present invention completed the method for manufacturing bubbles of the present invention. That is, in the method for manufacturing bubbles of the present invention, by changing the kind and/or amount of the additive added to the
aqueous liquid 10, the diameter of the generated bubbles 1 is adjusted. - The additive added to the
aqueous liquid 10 preferably includes at least one kind of additive among a protein, salts, and sugars. By using these additives, thebubbles 1 can be more reliably stabilized. The generated bubbles 1 are constituted with thegas 3, and it is considered that either or both of a molecule of the additive and a component (for example, an ion, a radical, and the like) derived from the additive may be adsorbed onto (exist on) a portion of the surfaces (gas-liquid interface) of thebubbles 1. That is, it is considered that the surfaces of thebubbles 1 may be incompletely covered with the molecule of the additive and/or the component derived from the additive. - Examples of the protein include albumin, globulin, and the like. Examples of the salts include NaCl, KC1, Na2HPO4, KH2PO4, C3H5NaO3, and the like. Examples of the sugars (including polysaccharide) include glucose, sucrose, dextrin, and the like.
- As the
aqueous liquid 10 to which the salts are added, for example, physiological saline (0.9 w/v % aqueous NaCl solution) and phosphate buffered saline (PBS) can be used. As theaqueous liquid 10 to which the salts and sugars are added, for example, Nos. 1 to 4 infusion solutions (electrolyte solutions) can be used. As theaqueous liquid 10 to which the protein is added, for example, an albumin preparation, a globulin preparation, and the like can be used. These are on the market as preparations. Therefore, by using these as they are, it is possible to simplify the manufacturing process of thebubbles 1 and reduce the manufacturing costs. - According to the method for manufacturing bubbles described above, even if the additive is not added to the
aqueous liquid 10, relativelystable bubbles 1 can be manufactured. Therefore, the amount of the additive added to theaqueous liquid 10 is preferably about 0 to 50 w/v %, more preferably about 0.1 to 40 w/v %, even more preferably about 0.5 to 30 w/v %, and particularly preferably about 1 to 20 w/v %. In a case where the amount of the additive added to theaqueous liquid 10 is set to be within the aforementioned range, highlystable bubbles 1 having the more uniform diameter can be manufactured, although manufacturing ofsuch bubbles 1 also depends on the kind of the additive. - According to the method for manufacturing bubbles described above, it is possible to easily manufacture the large amount of
bubbles 1 without requiring a large-scale system. Furthermore, because the sealed container (airtight container) is used for manufacturing thebubbles 1, in a case where the manufacturing container is filled with theaqueous liquid 10 and thegas 3 and then the interior of the container is subjected to a sterilization treatment such as γ-ray sterilization, thebubbles 1 can be manufactured in a sterile environment. Accordingly, thebubbles 1 manufactured in this way can be suitably used in the field of food or medical care. - The
bubbles 1 obtained as above can stably exist in theaqueous liquid 10. Therefore, the sealed container containing the obtained bubbles 1 can be stored for a long period of time, such as 6 to 24 months, at room temperature. Furthermore, even after the container is stored for such a long period of time, the number ofbubbles 1 in theaqueous liquid 10 substantially is not reduced. Therefore, the sealed container does not need to be vibrated again before use. Accordingly, the sealed container containing thebubbles 1 is easily handled in medical facilities and the like. In addition, because the sealed container having a small volume can be used, the unit cost of the sealed container can be reduced. - The obtained bubbles 1 (bubble-containing liquid) are used for making an ultrasonic diagnosis for patients.
- Specifically, first, an injection needle of a syringe is pierced into the rubber stopper of the sealed container. Then, the bubble-containing liquid is aspirated into the syringe from the interior of the sealed container. Thereafter, the injection needle is pulled out of the rubber stopper, and a blood vessel (for example, a vein) of a patient is pierced by the injection needle such that the bubble-containing liquid is injected into the blood vessel. In this way, the
bubbles 1 are transported to the affected site (target site of diagnosis) through the blood flow. - Then, at the timing when the
bubbles 1 reach a target site of diagnosis, thebubbles 1 are irradiated with ultrasonic waves for diagnosis having a frequency and an intensity at which thebubbles 1 may not burst (the ultrasonic waves are radiated to the bubbles 1). Then, the signals (reflection echo) reflected from the target site of diagnosis are received and subjected to data processing, thereby imaging the target site of diagnosis. In this way, an ultrasonic diagnosis can be made. - As a device performing the irradiation of the ultrasonic waves and receiving the reflection waves from the
bubbles 1, known ultrasonic probes can be used. - The
bubbles 1 can be used in various fields, in addition to being used for the ultrasonic diagnosis. For example, thebubbles 1 exhibit a germicidal effect with respect to water or food and have an effect of keeping the freshness of food. Furthermore, in an aqueous liquid containing thebubbles 1, water, and oil (hydrophobic component), a large amount of oil can be mixed with water. By exploiting such an effect, it is possible to cook with inhibiting the separation of water from oil in food. Accordingly, the bubble-containing liquid containing thebubbles 1 can also be used in the field of food. - As described above, the
bubbles 1 have the diameter of about 10 to 1,000 nm. In a case where thebubbles 1 having the diameter within the above range are injected into the blood vessel by the injection, the bubbles are smoothly transported in the blood vessel due to the blood flow. Particularly, the bubbles 1 (nanobubbles) having the diameter of about 200 to 300 nm are highly stable in a blood vessel. Therefore, such bubbles are reliably transported to a target site practically without being destroyed. - Generally, bubbles constituted with a gas have a property of efficiently reflecting the ultrasonic waves from an interface between a liquid and a gas. Therefore, in the
bubbles 1 having the diameter within the aforementioned range, an area of the interface between thegas 3 and theaqueous liquid 10 is large enough, and hence thebubbles 1 are effectively used as an ultrasound contrast agent. Particularly, the nanobubbles exhibit sufficiently high stability. Therefore, the nanobubbles can be used as the ultrasound contrast agent and actively used in various fields described above. - At an affected site where a cancer cell exists, neovessels having a diameter smaller than that of a normal blood vessel extend to the cancer cell from the normal blood vessels around the affected site. The nanobubbles can be smoothly transported even in the neovessels and can reach the cancer cell. Then, by irradiating the
bubbles 1 with the therapeutic ultrasonic waves having a frequency and intensity at which the bubbles can burst, it is possible to induce death of the cancer cell. That is, the nanobubbles can be suitably used for cancer treatment. Furthermore, some of the nanobubbles can be passed through the wall of the blood vessel and incorporated into the cancer cell. - The
bubbles 1 having the diameter of about 600 to 900 nm can be smoothly transported in blood vessels in the brain, and a position thereof can be clearly specified in an ultrasonic image. Therefore, thebubbles 1 can be suitably used in brain treatment (for example, endovascular treatment of brain). - The diameter (average diameter) of the
bubbles 1 can be measured by observation using, for example, a laser diffraction-scattering method, a nanoparticle tracking analysis method, an electric resistance method, an atomic force microscope (AFM), a laser microscope, and the like. - As a device for measuring by AFM, for example, it is possible to use a resonant particle measurement system (trade name: ARCHIMEDES) manufactured by Malvern Instruments Ltd.
- In the above description, by performing Steps [S1] to [S5], the large amount of
bubbles 1 having the uniform diameter can be stably manufactured in themanufacturing container 20. However, in the method for manufacturing bubbles, for example, Steps [S4] and [S5] may be repeated, and in this way, thebubbles 1 having the more uniform diameter can be stably generated. - Next, a second embodiment of the method for manufacturing bubbles of the present invention will be described.
-
FIG. 4 is a flow chart for illustrating the second embodiment of the method for manufacturing bubbles of the present invention.FIGS. 5(a) to 5(d) are views (cross-sectional views of a bubble manufacturing container) for illustrating the second embodiment of the method for manufacturing bubbles of the present invention. - In the following description, the upper side in each of
FIGS. 5(a) to 5(d) will be referred to as “top”, and the lower side in each ofFIGS. 5(a) to 5(d) will be referred to as “bottom”. - Hereinafter, regarding the method for manufacturing bubbles of the second embodiment, differences between the method for manufacturing bubbles of the first embodiment and the method for manufacturing bubbles of the present embodiment will be mainly described, and the same details will not be described.
- The method for manufacturing bubbles of the present embodiment is the same as the method for manufacturing bubbles of the first embodiment described above, except that as shown in
FIG. 4 , in Step [S3] of the first embodiment, themanufacturing container 20 is filled with thegas 3 and sealed in a state where the interior of themanufacturing container 20 is pressurized. - [S1] Preparation Step
- First, the
aqueous liquid 10 and themanufacturing container 20 of the first embodiment described above are prepared. - [S2] Step of Injecting Aqueous Liquid into Manufacturing Container
- Then, in the same manner as in the first embodiment described above, the
aqueous liquid 10 is injected into themanufacturing container 20. - [S3] Step of Sealing Manufacturing Container
- Thereafter, the
container body 21 is filled with thegas 3 and sealed in a state where the interior of themanufacturing container 20 is pressurized (seeFIG. 5(b) ). Specifically, by using thegas 3, purging is performed in thevoid portion 11 of thecontainer body 21 into which theaqueous liquid 10 is injected, and then thelid 22 is fastened to the opening portion (vial mouth) of thecontainer body 21. In this way, theaqueous liquid 10 and thegas 3 are sealed in themanufacturing container 20. - Then, a syringe filled with the
gas 3 is prepared, and an injection needle of the syringe is pierced into therubber stopper 221. Thereafter, thegas 3 is further added into themanufacturing container 20 from the syringe, thereby pressurizing the interior of themanufacturing container 20. Subsequently, the injection needle is pulled out of therubber stopper 221. In this way, it is possible to obtain themanufacturing container 20 which is sealed in a state where the interior thereof is pressurized due to thegas 3. - [S4] Step of Vibrating Manufacturing Container
- Then, in the same manner as in the first embodiment described above, the
manufacturing container 20 is vibrated such that theaqueous liquid 10 repeatedly collides with the top and bottom surfaces and the lateral surface of themanufacturing container 20. - [S5] Step of Allowing Manufacturing Container to Stand
- Subsequently, in the same manner as in the first embodiment described above, the
manufacturing container 20 is allowed to stand. - In the method for manufacturing bubbles of the present embodiment, in Step [S3], the interior of the
manufacturing container 20 is caused to be in the state of being pressurized due to thegas 3, and in this way, a portion of thegas 3 is in a state of being micro-dispersed or dissolved in theaqueous liquid 10. Accordingly, in Step [S4], thebubbles 1 easily occur in theaqueous liquid 10, and hencemore bubbles 1 having the uniform size can be manufactured than in the method for manufacturing bubbles of the first embodiment described above. Furthermore, thebubbles 1 having a diameter smaller than in the first embodiment can be generated. - The internal pressure (pressure of the
gas 3 with which thevoid portion 11 is filled) of themanufacturing container 20 in Step [S3] is preferably higher than 1.0 atm, more preferably 1.5 to 10 atm, and even more preferably 2 to 5 atm. In this way, a large amount ofgas 3 can be micro-dispersed or dissolved in theaqueous liquid 10. - With the method for manufacturing bubbles of the second embodiment, the same operations and effects as in the method for manufacturing bubbles of the first embodiment are also obtained.
- Next, a third embodiment of the method for manufacturing bubbles of the present invention will be described.
-
FIG. 6 is a flow chart for illustrating the third embodiment of the method for manufacturing bubbles of the present invention. - Hereinafter, regarding the method for manufacturing bubbles of the third embodiment, the differences between the methods for manufacturing bubbles of the first and second embodiments and the method for manufacturing bubbles of the present embodiment will be mainly described, and the same details will not be described.
- As shown in
FIG. 6 , the method for manufacturing bubbles of the present embodiment includes, after Steps [S1] to [S5] of the first embodiment described above, Step [S6] and Step [S7]. Step [S6] is a step of changing the internal pressure of the manufacturing container. Step [S7] is a step of setting the number of revolution at which the manufacturing container is vibrated. - In a case where the number of revolution is not changed in Step [S7] (in a case where “NO” is selected in Step [S7] in
FIG. 6 ), the method for manufacturing bubbles of the present embodiment further includes Step [S4′] and Step [S5′]. In contrast, in a case where the number of revolution is changed in Step [S7] (in a case where “YES” is selected in Step [S7] inFIG. 6 ), the method for manufacturing bubbles of the present embodiment further includes Step [S8] and Step [S9]. Furthermore, the method for manufacturing bubbles of the present embodiment includes Step [S10] of changing the internal pressure of the manufacturing container. Hereinafter, each of the steps following Step [S6] will be sequentially described. - [S6] Step of Changing Internal Pressure of Manufacturing Container
- The internal pressure of the
manufacturing container 20 having undergone Step [S5] of the second embodiment described above is changed. - (1) Case where internal pressure of manufacturing container is made higher than pressure in Step [S3]
- The interior of the
manufacturing container 20 is pressurized in the same manner as in the aforementioned Step [S3]. Thegas 3 to be injected may be the same as or different from thegas 3 used in Step [S3]. However, from the viewpoint of the stability of the finally generated bubbles, it is preferable to use thesame gas 3. - In such a
manufacturing container 20, the internal pressure of themanufacturing container 20 is further increased compared to the internal pressure of themanufacturing container 20 in Step [S3]. Therefore, the amount of thegas 3 which is micro-dispersed or dissolved in theaqueous liquid 10 becomes larger than the amount of thegas 3 which is micro-dispersed or dissolved in theaqueous liquid 10 in Step [S3]. Consequently, when themanufacturing container 20 is vibrated again in Step [S4′] or Step [S8] which will be described later, thebubbles 1 are more easily generated, and as a result, the amount of the generated bubbles 1 increases. - Furthermore, a pressure higher than the pressure applied to the
bubbles 1 generated in Step [S4] is applied to theaqueous liquid 10. As a result, thebubbles 1 in the process generation are compressed under a higher pressure, and hence the diameter of thebubbles 1 is easily reduced. Accordingly, it is possible to generate thebubbles 1 having a diameter smaller than that of thebubbles 1 generated in Step [S4]. - In this case, the internal pressure of the
manufacturing container 20 is higher than the pressure in Step [S3] preferably by 0.5 atm or more, and more preferably by 1 to 10 atm. In this way, it is possible to more reliably generate thebubbles 1 having a diameter smaller than that of thebubbles 1 generated in Step [S4] described above. - (2) Case where internal pressure of manufacturing container is made higher than 1.0 atm but lower than pressure in Step [S3]
- First, an empty syringe is prepared, and then an injection needle of the syringe is pierced into the
rubber stopper 221. Thereafter, thegas 3 in themanufacturing container 20 is aspirated into the syringe. In this way, the internal pressure of themanufacturing container 20 is reduced. Then, the injection needle is pulled out of therubber stopper 221. - In the
manufacturing container 20, when themanufacturing container 20 is vibrated again in Step [S4′] or Step [S8] which will be described later, the pressure applied to theaqueous liquid 10 is lower than the pressure applied to theaqueous liquid 10 generated in Step [S4]. As a result, thebubbles 1 in the process of generation are compressed less, and hence the size of thebubbles 1 easily increases. Therefore, it is possible to generate thebubbles 1 having a diameter larger than that of thebubbles 1 generated in Step [S4]. - In this case, the internal pressure of the
manufacturing container 20 is appropriately adjusted within such a range that the internal pressure becomes higher than 1.0 atm but is lower than the pressure in Step [S3]. - [S7] Step of setting number of revolution at which manufacturing container is vibrated.
- After the internal pressure of the
manufacturing container 20 is changed as described above, the number of revolution at which the manufacturing container is vibrated again is set. - As in Step [S4] described above, the number of revolution at the time of vibrating again the container is set to be equal to or higher than 5,000 rpm.
- In Step [S7], in a case where the number of revolution at the time of vibrating again the
manufacturing container 20 is not changed from the number of revolution in Step [S4], that is, in a case where “NO” is selected in Step [S7] inFIG. 6 , the following Step [S4′] is performed. - On the other hand, in Step [S7], in a case where the number of revolution at the time of vibrating again the
manufacturing container 20 is changed from the number of revolution in Step [S4], that is, in a case where “YES” is selected in Step [S7] inFIG. 6 , the following Step [S8] is performed. - [S4′] Step of Vibrating Again Manufacturing Container
- In the manner described above, the
manufacturing container 20 whose internal pressure is changed is vibrated again at the same number of revolution as in Step [S4] described above. In this way, thebubbles 1 having a diameter different from that of thebubbles 1 generated in Step [S4] are generated in theaqueous liquid 10. - In this step, the
manufacturing container 20 is vibrated again at the same number of revolution as in Step [S4]. Therefore, the diameter of thebubbles 1 newly generated in the present embodiment changes according to the pressure changed in Step [S6]. That is, by changing the pressure, the diameter of thebubbles 1 can be adjusted. Consequently, according to the change of the kind and/or amount of the additive added to the aqueous liquid, thebubbles 1 having different intended diameters (average diameters) can be manufactured with excellent reproducibility. Furthermore, because the setting of a device vibrating themanufacturing container 20 does not need to be changed, thebubbles 1 having the different diameters can be manufactured in a simpler manner. - [S5′] Step of Allowing Manufacturing Container to Stand
- After the
manufacturing container 20 is vibrated under the aforementioned condition, themanufacturing container 20 is allowed to stand in the same manner as in Step [S5]. In this way, the large amount ofbubbles 1 having the different sizes can be stably manufactured in themanufacturing container 20. - After the container is allowed to stand, Step [S10] is performed.
- [S8] Step of Vibrating Again Manufacturing Container
- The
manufacturing container 20 whose internal pressure is changed is vibrated again at the number of revolution different from that in Step [S4] described above. In this way, thebubbles 1 having a diameter different from that of thebubbles 1 generated in Step [S4] are generated in theaqueous liquid 10. - (1) Case where manufacturing container is vibrated again at number of revolution higher than that in Step [S4]
- The
manufacturing container 20 is vibrated again in the same manner as in Step [S4] described above, except that the number of revolution at which themanufacturing container 20 is vibrated is made higher than the number of revolution in Step [S4]. - In this case, the number of revolution of the
manufacturing container 20 is not particularly limited as long as it is higher than the number of revolution in Step [S4]. The number of revolution in this case is preferably 6,000 to 20,000 rpm, and more preferably 7,000 to 20,000 rpm. In this way, because themanufacturing container 20 is vibrated at the number of revolution higher than that in Step [S4], it is possible to generate thebubbles 1 having a diameter smaller than that of thebubbles 1 generated in Step [S4]. Furthermore, by setting the number of revolution of themanufacturing container 20 within the aforementioned range, it is possible to more reliably prevent thebubbles 1 generated in Step [S4] and the present step from being destroyed due to collision or from coarsening by being combined with each other. As a result, it is possible to manufacture thebubbles 1 generated in Step [S4] and thebubbles 1 having a diameter smaller than that of thebubbles 1 generated in Step [S4]. - (2) Case where manufacturing container is vibrated again at number of revolution lower than that in Step [S4]
- The
manufacturing container 20 is vibrated again in the same manner as in Step [S4], except that the number of revolution at which themanufacturing container 20 is vibrated is made lower than that in Step [S4]. - In this case, the number of revolution of the
manufacturing container 20 is not particularly limited as long as it is lower than the number of revolution in Step [S4]. The number of revolution in this case is preferably 5,000 to 9,000 rpm, and more preferably 5,500 to 7,500 rpm. In this way, themanufacturing container 20 is vibrated at the number of revolution lower than that in Step [S4], and hence thebubbles 1 having a diameter larger than that of thebubbles 1 generated in Step [S4] can be generated. Furthermore, by setting the number of revolution of themanufacturing container 20 to be within the aforementioned range, it is possible to more reliably prevent thebubbles 1 generated in Step [S4] and the present step from being destroyed due to the collision or from coarsening by being combined with each other. As a result, it is possible to manufacture thebubbles 1 generated in Step [S4] and thebubbles 1 having a diameter larger than that of thebubbles 1 generated in Step [S4]. - In this step, the
manufacturing container 20 is vibrated again at the number of revolution different from that in Step [S4]. Therefore, the diameter of thebubbles 1 newly generated in the present embodiment changes according to the change of the internal pressure of themanufacturing container 20 and to the number of revolution at the time of vibrating again the container. In this way, by changing both the internal pressure of themanufacturing container 20 and the number of revolution at the time of vibrating again the container, it is possible to generate thebubbles 1 having a diameter greatly different from the diameter obtained in the second embodiment described above. Accordingly, in a case where thebubbles 1 that greatly differ from each other in terms of the average diameter are manufactured, the present step is advantageous. - [S9] Step of allowing manufacturing container to stand After the
manufacturing container 20 is vibrated in Step [S8], themanufacturing container 20 is allowed to stand in the same manner as in Step [S5]. In this way, thebubbles 1 having the different diameters can be stably manufactured in themanufacturing container 20. - After the container is allowed to stand, Step [S10] is performed.
- [S10] Step of Changing Again Internal Pressure of Manufacturing Container
- In a case where the internal pressure of the
manufacturing container 20 is not changed, that is, in a case where “NO” is selected in Step [S10] inFIG. 6 , the method for manufacturing bubbles of the present embodiment is finished. In this way, two kinds of bubbles 1 (first bubbles and second bubbles) having different average diameters within a range of 10 nm to 1,000 nm are manufactured. - In contrast, in a case where the internal pressure of the
manufacturing container 20 is changed, that is, in a case where “YES” is selected in Step [S10] inFIG. 6 , Step [S7] is performed. Then, Steps [S4′], [S5′], and [S10] described above or Steps [S8], [S9], and [S10] are repeated. In this way, it is possible to manufacture thebubbles 1 having a plurality of different average diameters within a range of 10 nm to 1,000 nm. - In a case where the pressure is repeatedly changed in Step [S10], it is possible to manufacture the
bubbles 1 having the plurality of different average diameters according to the number of times the pressure is changed. - In the manner described so far, the bubble-containing liquid is obtained which contains the
bubbles 1 having the different diameters in theaqueous liquid 10. The ease of passing thebubbles 1 in blood vessels and the site to which the bubbles are transported vary with the difference in the size (for example, the smaller the diameter of thebubbles 1 is, the farther thebubbles 1 can be transported toward the end of a capillary). Therefore, the bubble-containing liquid obtained as above can be used in many ways according to the purpose of the ultrasonic diagnosis and/or the ultrasound therapy. - With the method for manufacturing bubbles of the third embodiment, the same operations and effects as in the methods for manufacturing bubbles of the first to second embodiments are also obtained.
- 1. Manufacturing of Bubbles
- Bubbles were Manufactured in the Following Manner.
- [Preparation Step]
- Frist, 12 ml of distilled water (aqueous liquid) was prepared, and a 15 ml vial (height X: 50 mm, outer diameter R: 25 mm) was prepared. The vial had the same shape as that of the
manufacturing container 20 shown inFIG. 2 . - [Step of Injecting Distilled Water into Container]
- The distilled water was injected into the prepared vial. A height Y of a surface of the distilled water was 25 mm.
- [Step of Sealing Container]
- Then, by using perfluoropropane (gas), purging was performed in a void in the vial into which the distilled water was injected, and then a lid having the same shape as that of the
lid 22 shown inFIG. 2 was inserted into the mouth of the vial. Thereafter, a syringe filled with perfluoropropane was prepared. An injection needle of the syringe was pierced into the rubber stopper of the lid, and 2 ml of perfluoropropane was further added into the vial from the syringe. In this way, a sealed vial having an internal pressure of 2 atm was obtained. - [Step of Vibrating Container]
- Then, by using Precellys (high-speed cell disruption system) manufactured by bertin Technologies, the sealed vial was vibrated for 30 seconds at the number of revolution of 6,500 rpm. At this time, the sealed vial was caused to reciprocate up and down, and it was confirmed that the distilled water repeatedly collides with the top and bottom surfaces of the sealed vial.
- When the sealed vial was vibrated, a vibration width of the sealed vial was set to be 40 mm in a vertical direction and 20 mm in a horizontal direction, such that an instantaneous relative speed between vial and the distilled water became equal to or higher than 40 km/h.
- [Step of Allowing Container to Stand]
- After being vibrated, the sealed vial was allowed to stand, thereby obtaining a bubble-containing liquid containing bubbles constituted with perfluoropropane in the distilled water.
- Bubbles were generated and a bubble-containing liquid was manufactured in the same manner as in Example 1, except that the distilled water was changed to a 1 w/v % aqueous dextrin solution.
- Bubbles were generated and a bubble-containing liquid was manufactured in the same manner as in Example 1, except that the distilled water was changed to PBS.
- Bubbles were generated and a bubble-containing liquid was manufactured in the same manner as in Example 1, except that the distilled water was changed to a SOLDEM 3 A infusion solution (manufactured by Terumo Corporation).
- Bubbles were generated and a bubble-containing liquid was manufactured in the same manner as in Example 1, except that the distilled water was changed to a
SOLDEM 1 infusion solution (manufactured by Terumo Corporation). - Bubbles were generated and a bubble-containing liquid was manufactured in the same manner as in Example 1, except that the distilled water was changed to physiological saline (0.9 w/v % aqueous NaCl solution).
- Bubbles were generated and a bubble-containing liquid was manufactured in the same manner as in Example 1, except that the distilled water was changed to a 0.25 w/v % aqueous albumin solution.
- Bubbles were generated and a bubble-containing liquid was manufactured in the same manner as in Example 1, except that the distilled water was changed to a 20 w/v % aqueous glucose solution.
- Bubbles were generated and a bubble-containing liquid was manufactured in the same manner as in Example 1, except that the distilled water was changed to a 5 w/v % aqueous glucose solution.
- Bubbles were generated and a bubble-containing liquid was manufactured in the same manner as in Example 1, except that the distilled water was changed to a 10 w/v % aqueous glucose solution.
- Bubbles were generated and a bubble-containing liquid was manufactured in the same manner as in Example 1, except that the distilled water was changed to a 40 w/v % aqueous glucose solution.
- Bubbles were generated and a bubble-containing liquid was manufactured in the same manner as in Example 1, except that the distilled water was changed to a 50 w/v % aqueous glucose solution.
- 2. Measurement of Diameter Distribution of Bubbles
- The bubble-containing liquid obtained as above was set in a bubble measurement device (nanoparticle analysis system nanosight), and diameter distributions of the bubbles contained in the bubble-containing liquid (aqueous liquid) was measured.
FIGS. 7 and 8 show results. - As shown in
FIG. 7 , it is understood that depending on whether or not an additive is added to the aqueous liquid, the diameter of the generated bubbles changes. Furthermore, it is understood that the diameter of the generated bubbles also varies with the kind and amount of the additive added to the aqueous liquid. - As shown in
FIG. 8 , it is understood that in a case where the same additive (glucose) is used, by changing the amount of the additive added to the aqueous liquid, the diameter of the generated bubbles also changes. The inventor of the present invention confirmed that in a case where different additives are added to the aqueous liquid in the same amount, that is, in a case where only the kind of the additive is changed, the diameter of the generated bubbles changes, although this result is not shown in the drawing. - As in the first embodiment, in a case where the interior of the sealed vial is not pressurized in the step of sealing the container, the diameter of the generated bubbles tends to increase. Furthermore, even in a case where the bubbles are manufactured in the same manner as in the third embodiment, according to the kind and/or amount of the additive added to the aqueous liquid, the diameter of the generated bubbles could change.
- Hitherto, the method for manufacturing bubbles of the present invention has been described based on the embodiments shown in drawings, but the present invention is not limited thereto.
- For example, the method for manufacturing bubbles of the present invention may additionally include one or more steps for a certain purpose.
- In Step [S4] of the embodiments described above, by supplying the ultrasonic waves to the
aqueous liquid 10 and thegas 3, vibration (external force) may be caused. In this case, the ultrasonic waves preferably have a frequency of about 20 kHz to 10 MHz (particularly, about 200 kHz to 1 MHz) and an intensity of about 10 mW/cm2 to 1,000 mW/cm2 (particularly, about 100 mW/cm2 to 100 W/cm2). - The method for manufacturing bubbles of the present invention includes a step of mixing an aqueous liquid with a gas with applying an external force to the aqueous liquid and the gas such that a plurality of bubbles constituted with the gas are generated in the aqueous liquid, in which in this step, a diameter of the bubbles generated is adjusted by changing a kind and/or an amount of an additive added to the aqueous liquid. In this way, it is possible to provide a method for manufacturing bubbles that makes it possible to easily and reliably adjust a diameter of the generated bubbles. Accordingly, the present invention is industrially applicable.
- 1 . . . bubbles, 3 . . . gas, 10 . . . aqueous liquid, 11 . . . void portion, 20 . . . manufacturing container, 21 . . . container body, 22 . . . lid, 221 . . . rubber stopper, 222 . . . fastening portion
Claims (10)
1. A method for manufacturing bubbles, comprising:
mixing an aqueous liquid with a gas; and
applying an external force to the aqueous liquid and the gas to generate a plurality of bubbles constituted with the gas in the aqueous liquid,
wherein a diameter of the bubbles to be generated is adjusted by changing a kind and/or an amount of an additive to be added to the aqueous liquid.
2. The method for manufacturing bubbles according to claim 1 ,
wherein the additive to be added to the aqueous liquid includes at least one kind of additive among a protein, salts, and sugars.
3. The method for manufacturing bubbles according to claim 1 ,
wherein the amount of the additive added to the aqueous liquid is in the range of 0 to 50 w/v %.
4. The method for manufacturing bubbles according to claim 1 ,
wherein in a case where the additive is added to the aqueous liquid, a molecule of the additive and/or a component derived from the additive exist in a portion of a gas-liquid interface which is a surface of each of the bubbles and is between the gas and the aqueous liquid.
5. The method for manufacturing bubbles according to claim 1 ,
wherein the external force is vibration.
6. The method for manufacturing bubbles according to claim 5 ,
wherein the aqueous liquid and the gas are added into a container, and
the container is vibrated such that the aqueous liquid repeatedly collides with an inner surface of the container.
7. The method for manufacturing bubbles according to claim 6 ,
wherein the container has a long shape and is vibrated to reciprocate in a longitudinal direction of the container and/or rotate mainly in the longitudinal direction.
8. The method for manufacturing bubbles according to claim 6 ,
wherein the container has a long shape and is vibrated to reciprocate in a transverse direction of the container and/or rotate mainly in the transverse direction.
9. The method for manufacturing bubbles according to claim 6 ,
wherein the container is vibrated in a state where an internal pressure of the container is higher than 1.0 atm.
10. The method for manufacturing bubbles according to claim 6 ,
wherein the container is vibrated at a number of revolution of equal to or higher than 5,000 rpm.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2015079625 | 2015-04-08 | ||
JP2015-079625 | 2015-04-08 | ||
PCT/JP2016/061294 WO2016163415A1 (en) | 2015-04-08 | 2016-04-06 | Bubble production method |
Publications (1)
Publication Number | Publication Date |
---|---|
US20180085477A1 true US20180085477A1 (en) | 2018-03-29 |
Family
ID=57072577
Family Applications (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US15/565,111 Abandoned US20180085477A1 (en) | 2015-04-08 | 2016-04-06 | Method for manufacturing bubbles |
US15/565,104 Active 2037-07-28 US10959960B2 (en) | 2015-04-08 | 2016-04-07 | Bubble manufacturing container |
US15/565,118 Active 2036-12-01 US10857104B2 (en) | 2015-04-08 | 2016-04-07 | Method for manufacturing bubbles and bubbles |
US17/180,465 Active 2037-04-08 US11786478B2 (en) | 2015-04-08 | 2021-02-19 | Bubble manufacturing container |
Family Applications After (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US15/565,104 Active 2037-07-28 US10959960B2 (en) | 2015-04-08 | 2016-04-07 | Bubble manufacturing container |
US15/565,118 Active 2036-12-01 US10857104B2 (en) | 2015-04-08 | 2016-04-07 | Method for manufacturing bubbles and bubbles |
US17/180,465 Active 2037-04-08 US11786478B2 (en) | 2015-04-08 | 2021-02-19 | Bubble manufacturing container |
Country Status (5)
Country | Link |
---|---|
US (4) | US20180085477A1 (en) |
EP (4) | EP3281691A4 (en) |
JP (5) | JP6181341B2 (en) |
CN (3) | CN107708847A (en) |
WO (3) | WO2016163415A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10857104B2 (en) * | 2015-04-08 | 2020-12-08 | Sonocore, Inc. | Method for manufacturing bubbles and bubbles |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP6547074B6 (en) * | 2016-11-29 | 2020-03-18 | SonoCore株式会社 | Bubble holding agent-containing liquid and method for producing bubble-containing liquid |
US12005130B2 (en) * | 2019-10-16 | 2024-06-11 | Agitated Solutions Inc. | Generating microbubbles for bubble studies |
CN110980915B (en) * | 2019-12-23 | 2022-08-02 | 解冰 | Application of nano oxygen free radical water in anticancer medicine |
US11191888B1 (en) * | 2020-05-18 | 2021-12-07 | Agitated Solutions Inc. | Syringe-based microbubble generator |
US20230166221A1 (en) * | 2021-11-29 | 2023-06-01 | Todd Carmichael | Effervescent beverage in valveless container aerated with sparingly soluble gases, and apparatuses and methods for making the same |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5656211A (en) * | 1989-12-22 | 1997-08-12 | Imarx Pharmaceutical Corp. | Apparatus and method for making gas-filled vesicles of optimal size |
US20120270177A1 (en) * | 2009-12-16 | 2012-10-25 | Fukuoka University | Dental ultrasonic drug delivery system and dental ultrasonic drug delivery method |
US20130022550A1 (en) * | 2011-07-19 | 2013-01-24 | Unger Evan C | Microbubble Compositions, Method of Making Same, and Method Using Same |
Family Cites Families (59)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3826059A (en) * | 1971-10-19 | 1974-07-30 | New England Nuclear Corp | Method of packaging radioactive materials |
JPS6064623A (en) | 1983-09-16 | 1985-04-13 | Fumitaka Hirozawa | Mixer apparatus |
DE3687824D1 (en) * | 1985-12-05 | 1993-04-01 | Abs Int Sa | DEVICE FOR FUMING LIQUIDS OR FOR MIXING LIQUIDS. |
JPH02107325A (en) | 1988-10-17 | 1990-04-19 | Koei Sangyo Kk | Stirring apparatus and method |
US5039557A (en) | 1989-10-26 | 1991-08-13 | White Terrence H | Method for embedding reflective beads in thermoplastic pavement marking lines |
US5580575A (en) | 1989-12-22 | 1996-12-03 | Imarx Pharmaceutical Corp. | Therapeutic drug delivery systems |
US5776429A (en) * | 1989-12-22 | 1998-07-07 | Imarx Pharmaceutical Corp. | Method of preparing gas-filled microspheres using a lyophilized lipids |
US5773024A (en) * | 1989-12-22 | 1998-06-30 | Imarx Pharmaceutical Corp. | Container with multi-phase composition for use in diagnostic and therapeutic applications |
US5230427A (en) * | 1991-06-12 | 1993-07-27 | Ppg Industries, Inc. | Sterilizable hermetically-sealed substantially glass container |
US7083572B2 (en) * | 1993-11-30 | 2006-08-01 | Bristol-Myers Squibb Medical Imaging, Inc. | Therapeutic delivery systems |
JP3396319B2 (en) * | 1993-12-28 | 2003-04-14 | 浜松ホトニクス株式会社 | Liquid processing method and liquid processing apparatus |
US5829607A (en) * | 1994-06-10 | 1998-11-03 | Ibrahim; Moheb M. | Double ended bottle |
US6039309A (en) * | 1997-12-05 | 2000-03-21 | The United States Of America As Represented By The Secretary Of The Navy | Method and apparatus for producing gas bubbles in a liquid medium |
WO1999046047A2 (en) * | 1998-03-10 | 1999-09-16 | Large Scale Proteomics Corporation | Detection and characterization of microorganisms |
JPH11347391A (en) * | 1998-06-04 | 1999-12-21 | Kinsuke Yamawaki | Shake-up machine and method therefor |
US6464671B1 (en) * | 1999-04-28 | 2002-10-15 | Sten-Olof Elver | Medical system |
US6452200B1 (en) * | 1999-05-13 | 2002-09-17 | Mds Nordion Inc. | Gap shielded container for a radioactive source |
JP4712980B2 (en) * | 2001-01-18 | 2011-06-29 | 株式会社日立メディコ | Ultrasonic device |
US6685148B2 (en) * | 2002-04-24 | 2004-02-03 | Adam Zadok | Support for hand held video camera |
US20030224867A1 (en) * | 2002-06-01 | 2003-12-04 | Dean Ota | Golf swing training club with adjustable weight |
US20040009826A1 (en) * | 2002-07-12 | 2004-01-15 | Aisenberg Jeremy C. | Golf swing training device |
JP2004237271A (en) | 2003-02-05 | 2004-08-26 | Fukuda Sangyo:Kk | Oxygen water making method and oxygen water making container |
JP2004255222A (en) * | 2003-02-24 | 2004-09-16 | Sanyo Electric Co Ltd | Shaking apparatus |
JP2005154282A (en) * | 2003-11-20 | 2005-06-16 | Mebiopharm Co Ltd | Method for producing gas-sealed liposome |
JP4080440B2 (en) | 2004-03-05 | 2008-04-23 | 独立行政法人産業技術総合研究所 | Oxygen nanobubble water and method for producing the same |
CN101389273B (en) * | 2004-08-05 | 2012-09-05 | 贝勒研究院 | Gene or drug delivery system |
WO2006028959A2 (en) * | 2004-09-03 | 2006-03-16 | Imarx Therapeutics, Inc. | Apparatus and method to prepare a microsphere-forming composition |
CN101233579B (en) * | 2005-07-27 | 2013-07-10 | 马林克罗特有限公司 | Radiation-shielding assemblies and methods of using the same |
US20070187429A1 (en) * | 2006-02-15 | 2007-08-16 | Bardia Farahmand | Dual opening tubular dispenser |
GB0604591D0 (en) * | 2006-03-07 | 2006-04-19 | Glaxosmithkline Biolog Sa | Novel device |
US7914499B2 (en) * | 2006-03-30 | 2011-03-29 | Valeritas, Inc. | Multi-cartridge fluid delivery device |
US7900658B2 (en) * | 2006-10-20 | 2011-03-08 | Fht, Inc. | Automated drug preparation apparatus including drug vial handling, venting, cannula positioning functionality |
WO2008051900A2 (en) | 2006-10-25 | 2008-05-02 | Services Petroliers Schlumberger | High accuracy contamination estimation in hydrocarbon samples using gc x gc |
US20080264895A1 (en) * | 2007-04-28 | 2008-10-30 | Bella Prieto | Double opening wide mouth food jar with screw caps |
JP5124185B2 (en) * | 2007-07-02 | 2013-01-23 | 株式会社日立製作所 | Method and apparatus for preparing a diagnostic or therapeutic drug |
CN101130095A (en) * | 2007-07-24 | 2008-02-27 | 重庆润琪医药科技开发有限公司 | Lipid microvesicle ultrasound angiography powder agent internally containing mixture gas of fluorine carbon/nitrogen gas and production of the same |
ATE480316T1 (en) * | 2007-07-26 | 2010-09-15 | Wmf Wuerttemberg Metallwaren | DEVICE FOR MIXING WATER AND GAS |
US8439223B2 (en) * | 2007-08-20 | 2013-05-14 | The Procter & Gamble Company | Base cup for a supportable pressurizable container |
WO2009117688A2 (en) | 2008-03-21 | 2009-09-24 | The Board Of Trustees Of The University Of Arkansas | Methods for producing microbubbles |
US8365941B2 (en) * | 2009-05-15 | 2013-02-05 | David James Mayer | Dual-capped hydration bottle |
WO2011077434A1 (en) * | 2009-12-23 | 2011-06-30 | Medimop Medical Projects Ltd | Medical apparatus and single use kit including flow control device for use therewith for reconstitution and administration of liquid drug dosage |
US8206368B2 (en) * | 2010-01-18 | 2012-06-26 | Rourke M. Yeakley | Multi-chamber mixture dispensing system |
US8479919B2 (en) * | 2010-07-08 | 2013-07-09 | Accudial Pharmaceutical, Inc. | Injectable fluid vial housing |
US20140039072A1 (en) * | 2011-04-04 | 2014-02-06 | Waseda University | Method for producing vesicles |
DE102011079031A1 (en) * | 2011-07-12 | 2013-01-17 | Algeta Asa | liquid container |
US9095798B2 (en) * | 2011-08-19 | 2015-08-04 | Microaire Surgical Instruments, Llc | Centrifuge separation method and apparatus using a medium density fluid |
US8967896B2 (en) * | 2011-11-23 | 2015-03-03 | Dean Johnson | Cosmetic apparatus and method |
US9844846B2 (en) * | 2012-02-08 | 2017-12-19 | Tension International, Inc. | Container carrier |
CN104755108B (en) * | 2012-10-25 | 2018-04-27 | 艾姆戈特株式会社 | With reference to the ultrasonic contrast agents and its manufacture method of the nano-particle containing medicine |
US20140166033A1 (en) * | 2012-12-17 | 2014-06-19 | Charisma A. Declouet | Dual Cosmetic Dispenser |
CN104870048B (en) * | 2012-12-27 | 2018-11-30 | 医疗物理有限公司 | Shipping container |
KR102095829B1 (en) * | 2013-02-25 | 2020-04-01 | 가부시키가이샤 이와타 라벨 | Bottle container with bottle breakage-preventing function |
US9327886B2 (en) * | 2013-03-13 | 2016-05-03 | Bayer Healthcare Llc | Vial container with collar cap |
TWI552761B (en) * | 2013-05-03 | 2016-10-11 | 博信生物科技股份有限公司 | An lipid-based micro/nano-bubble, and an optimized preparing method and equipment thereof |
JP5629805B2 (en) | 2013-05-07 | 2014-11-26 | 株式会社かがやき | Nanobubble manufacturing method and nanobubble manufacturing apparatus |
CN103394102B (en) * | 2013-05-22 | 2018-08-07 | 博信生物科技股份有限公司 | A kind of lipid is micro-/preparation method and preparation facilities of nanometer bubble and its optimization |
DE102013017310B4 (en) * | 2013-07-02 | 2018-03-01 | Florian Enghard | Mixing bowl |
US9528250B2 (en) * | 2014-09-30 | 2016-12-27 | Delta Faucet Company | Hose weight for a faucet |
WO2016163415A1 (en) * | 2015-04-08 | 2016-10-13 | SonoCore株式会社 | Bubble production method |
-
2016
- 2016-04-06 WO PCT/JP2016/061294 patent/WO2016163415A1/en active Application Filing
- 2016-04-06 CN CN201680020456.1A patent/CN107708847A/en active Pending
- 2016-04-06 US US15/565,111 patent/US20180085477A1/en not_active Abandoned
- 2016-04-06 EP EP16776581.7A patent/EP3281691A4/en not_active Withdrawn
- 2016-04-06 JP JP2017511028A patent/JP6181341B2/en active Active
- 2016-04-07 JP JP2017511043A patent/JP6178947B2/en active Active
- 2016-04-07 US US15/565,104 patent/US10959960B2/en active Active
- 2016-04-07 US US15/565,118 patent/US10857104B2/en active Active
- 2016-04-07 WO PCT/JP2016/061354 patent/WO2016163443A1/en active Application Filing
- 2016-04-07 WO PCT/JP2016/061350 patent/WO2016163439A1/en active Application Filing
- 2016-04-07 JP JP2016544494A patent/JP6076555B1/en active Active
- 2016-04-07 EP EP16776605.4A patent/EP3281692A4/en not_active Withdrawn
- 2016-04-07 CN CN201680020365.8A patent/CN107847879A/en active Pending
- 2016-04-07 EP EP21187703.0A patent/EP3922345A1/en not_active Withdrawn
- 2016-04-07 EP EP16776609.6A patent/EP3281693B1/en active Active
- 2016-04-07 CN CN201680020439.8A patent/CN107847880A/en active Pending
- 2016-11-24 JP JP2016228333A patent/JP6831532B2/en active Active
-
2017
- 2017-07-19 JP JP2017140000A patent/JP2017205763A/en active Pending
-
2021
- 2021-02-19 US US17/180,465 patent/US11786478B2/en active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5656211A (en) * | 1989-12-22 | 1997-08-12 | Imarx Pharmaceutical Corp. | Apparatus and method for making gas-filled vesicles of optimal size |
US20120270177A1 (en) * | 2009-12-16 | 2012-10-25 | Fukuoka University | Dental ultrasonic drug delivery system and dental ultrasonic drug delivery method |
US20130022550A1 (en) * | 2011-07-19 | 2013-01-24 | Unger Evan C | Microbubble Compositions, Method of Making Same, and Method Using Same |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10857104B2 (en) * | 2015-04-08 | 2020-12-08 | Sonocore, Inc. | Method for manufacturing bubbles and bubbles |
Also Published As
Publication number | Publication date |
---|---|
JP6181341B2 (en) | 2017-08-16 |
JP2017205763A (en) | 2017-11-24 |
US20180116971A1 (en) | 2018-05-03 |
US20180104146A1 (en) | 2018-04-19 |
CN107847880A (en) | 2018-03-27 |
EP3281693B1 (en) | 2021-10-06 |
EP3281692A1 (en) | 2018-02-14 |
JP6831532B2 (en) | 2021-02-17 |
EP3281693A4 (en) | 2018-04-04 |
WO2016163415A1 (en) | 2016-10-13 |
US10959960B2 (en) | 2021-03-30 |
EP3281691A4 (en) | 2018-09-19 |
EP3281692A4 (en) | 2018-03-28 |
US10857104B2 (en) | 2020-12-08 |
JP6076555B1 (en) | 2017-02-08 |
JPWO2016163439A1 (en) | 2017-07-13 |
US20210244673A1 (en) | 2021-08-12 |
WO2016163443A1 (en) | 2016-10-13 |
JP6178947B2 (en) | 2017-08-09 |
CN107847879A (en) | 2018-03-27 |
EP3281691A1 (en) | 2018-02-14 |
EP3281693A1 (en) | 2018-02-14 |
WO2016163439A1 (en) | 2016-10-13 |
JPWO2016163443A1 (en) | 2017-04-27 |
EP3922345A1 (en) | 2021-12-15 |
US11786478B2 (en) | 2023-10-17 |
CN107708847A (en) | 2018-02-16 |
JP2017094325A (en) | 2017-06-01 |
JPWO2016163415A1 (en) | 2017-07-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20180085477A1 (en) | Method for manufacturing bubbles | |
JP6547074B2 (en) | Method for producing bubble-retaining agent-containing liquid and bubble-containing liquid | |
Loskutova et al. | Review on acoustic droplet vaporization in ultrasound diagnostics and therapeutics | |
JPWO2018101251A6 (en) | Bubble holding agent-containing liquid and method for producing bubble-containing liquid | |
JP5927325B1 (en) | Bubble production method | |
RU2631800C2 (en) | Method of filling container with foamed composition | |
JP5866055B1 (en) | Bubble production method | |
WO2017217344A1 (en) | Molecular targeting drug bubble and method for manufacturing same | |
JP6539215B2 (en) | Bubble manufacturing method | |
JP2018002611A (en) | Classifying method and classifying apparatus |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: SONOCORE, INC., JAPAN Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:TACHIBANA, KATSURO;REEL/FRAME:045195/0704 Effective date: 20171120 |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: FINAL REJECTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: FINAL REJECTION MAILED |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |